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Antibacterials alike have proven to be an invaluable breakthrough in the treatment of 
infectious diseases. Upon their introduction, countless lives were saved. However, bacteria 
have a profound ability to alter their susceptibility to antibiotics, rendering themselves 
resistant to one or more of the current antibiotics available[4,7,26,27]. As in the beginning of the 
twentieth century, thousands of people are again dying from infectious d seases that were 
once kept at bay due to the rise in antibiotic resistant bacteril st ains. Bacteria become 
resistant to newly introduced antibiotics very quickly[5]. Therefore, a new approach to 
treating bacterial infections is needed and may be accomplished by attenuating bacterial 
resistance mechanisms and sensitizing them to current antibiotics. RecA, a recombinase 
enzyme that is involved in various aspects of DNA repair, horizontal gene transfer and the 
induction of SOS mutagenesis[19-25], seems to be a promising target whose inhibition would 
preclude the RecA-dependent activities used by bacteria to reduce their susceptibility to 
antibiotics. Previous work completed by the Singleton research group has identified various 
classes of small molecules, peptides, inorganic cations and nucleotide analogs have been able 
to diminish the SOS response [50-52,55, 71-78]. Furthermore, unpublished results from our 
laboratory have identified cell-permeable small molecules that are bona fide inhibitors of 
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purified E. coli RecA and demonstrated that such inhibitors can attenuate SOS in live E. coli 
and potentiate E. coli killing by bactericidal agents.  In order to enhance the data validating 
RecA as a pharmaceutical target, it was of interest to assess whether such RecA inhibitors 
could also serve to block its function in horizontal gene transfer[27,27,37]. In this study, we 
evaluated whether cell-permeable RecA inhibitors could prevent the transfer of genetic 
material from heat-killed antibiotic-resistant E. coli to live, susceptible E. coli. It was 
demonstrated that one inhibitor identified from a previous screen (A1) attenuated the rate at 
which E. coli developed resistance to chloramphenicol in both the presence and absece of 
heat-killed chloramphenicol-resistant cells. However, the results also suggest that E. coli may 
have a RecA-indepedent pathway for developing resistance. Regardless of thi  possibility, 
the hit compound may reveal yet another unique means of impeding the spread of antibiotic 
resistance genes that could be unraveled in future studies, but does not di credit RecA from 
being a novel and promising target for battling antibiotic resistance. Although the latter 
results may obfuscate the critical path for developing RecA inhibitors as pharmaceutical 
agents, it should be emphasized that the results also demonstrate the power of biologically 
active small molecules to help elucidate complex biological processes.  To initiate the 
process of discovering next-generation RecA inhibitors suited to the task of teasing apart 
contributions of RecA to antibiotic resistance, collaborative studies w re undertaken to 
identify prospective inhibitors among virtual compound libraries. 
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Implications of Bacterial Drug Resistance 
 
Limited organisms in existence have the ability to thrive in every 
imaginable habit this earth has to offer. Bacteria, being unicellular 
microorganisms, are able to survive in water, soil, radioactive waste, acidic hot 
springs, even in the very living bodies of plants and animals. Millions of bacteria 
are present on the skin and within the human body at any given time. Bacteria are 
perceived as disease-causing, undesirable living organisms, despite the fact that 
their existence is vital to the cycles of the earth due to their capability to recycle 
nutrients. They are even beneficial to humans in that they aid in the health of the 
digestive tract by performing fermentation of unused energy substrates, 
controlling the growth of harmful bacterial species and producing valuable 
vitamins for their hosts. Most bacteria living in the human body are regulated by 
the immune system, but pathogenic strains do arise and cause infections diseases, 
thus bestowing bacteria with their ominous reputation.  
However, before the introduction of antimicrobials, communicable 
infectious diseases, including bacterial infections, claimed the lives of thousands 
of people every year. At the start of the twentieth century, diseases caused by 
bacteria ranked at the top among the top ten causes of death in the United States, 
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which included pneumonia (viral and bacterial), tuberculosis and diarrhea. 
Maintaining personal hygiene, reliance on the immune system and the use of 
crude plant extracts were not enough to contend with the microorganisms that 
caused these diseases. Attempts to discover agents that could have antibacterial 
effects were unsuccessfully made in the early 1900’s. Sulfa drugswere introduced 
in the early 1930’s as the first antimicrobial drugs, but due to adverse effects and 
toxicity issues, other antimicrobial agents were desired. Sulfa drugs paved the 
way for revolutionary agents like penicillin. Also in the 1930’s, Sir Alexander 
Fleming accidentally stumbled upon a petri dish growing Staphyloccocus 
contaminated with mold[1]. However, this plate showed lack of growth of the 
bacteria near the mold, thus indicating that it released a natural product that was 
lethal to the bacteria. Upon analysis of the mold, it was determined to be 
Penicillium notatum, and thus, the natural product being released from the mold 
was coined penicillin. Through collaborative efforts with Howard Florey and 
Ernst Chain, penicillin was shown to have bactericidal effects in vivo and proved 
effective in treating bacterial infections in mice[2]. In the 1940’s, penicillin was 
finally able to be mass-produced, which enabled it to be extensively us d to treat 
countless soldiers in World War II, allowing them to treat otherwise fatal and 
devastating wounds. The Nobel Prize was awarded to Fleming, Florey and Chain 
in 1945 in recognition of their discoveries. They paved the road for the 
introduction of other antibiotics which would lead to a great improvement of the 
quality of life by combating the infectious diseases that claimed the lives of so 
many in the beginning of the century. 
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 The introduction of antibiotics, which were viewed as “miracle drugs”, 
was considered to be one of the most imperative medical advancements of the 
twentieth century, giving a false sense of hope that humans had triumphed in the 
war against infectious diseases. Fleming himself foresaw and w rned against the 
dangers of resistance, stating that underdosage of an antibiotic easily caused 
microbes to develop resistance in the laboratory and in humans by not exposing 
them to a lethal dosage of the drug, thus allowing microbes to “educate” 
themselves on how to resist antibiotics[3]. Many battles had been victorious with 
the introduction of new and more effective agents, thus keeping bacterial 
resistance from becoming a major medical problem for decades, but resistance to 
antibacterials escalates today at an alarming rate.  
According to the Center for Disease Control and Prevention, two million 
people acquire bacterial infections in hospitals each year[4]. Ninety thousand of 
those people die from these infections due to approximately seventy percent of 
those infections being caused by a strain of bacteria that are resistant to one or 
more of the one-hundred or so available antibiotics[4]. These statistics account 
only for hospitalized patients. Millions more acquire infections outside of the 
hospitals. Because of the prevalence of resistant strains and the rapid onset of 
resistance to newly introduced antibiotics (Figure 1.1[5]), many doctors find 









A positive trend has been observed when reporting the amount of resistant 
strains infecting people in the United States. Starting from about 1980, the percent 
incidence of resistant strains was very low, less than 5% (Figure 1.2, left panel). 
However, over the course of twenty years, the percent incidence of rsistant 
strains has drastically increased to about 60% incidence for MRSA and 25-30% 
incidence for VRE and FQRP. The need for novel antibacterials is quite apparent, 
however, an inverse correlation is seen in the number of antibacterials approved 
in the United States over the same time span. A total of three new a tibiotics were 
approved for administration between 2003-2007 (Figure 1.2, right panel). How 
can this be when the need for such treatments is so great? Manylarge 
pharmaceutical companies, including Glaxo Smith-Kline, Wyeth, Aventis and 
Figure 1.1. Timeline of the introduction of new antibiotics vs. the reported resistance to 
the antibiotics. Many antibiotics introduced to the market often acquire resistance quickly 
after their introduction. The figure was reproduced from Clatworthy, et al. (2007) Nat. Chem. 
Biol. 3, 541-548.[5] 
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Bristol-Myers Squib, have eliminated or downsized their antibacterial r search[6]. 
This is due to the increased cost of drug discovery research, short-comings of 
target based drug discovery to unravel novel antibacterials, a shift of interest from 
short-term acute diseases to long-term chronic diseases and because the rapid 
onset of resistance to antibacterial agents gives them a short –lived market time 
frame. The cost to develop and market the drugs is far greater than the revenue 
they generate[6].  
The moral implications of this biological predicament outweigh the 
monetary demand. Therefore, the goal of this thesis was to further nd stand the 
implications of the RecA protein in bacterial resistance development and utilize it 
as a potential novel target in battling resistance onset and therefore battling 













Figure 1.2 Trends in the spread of bacterial resistant strains and approved antibiotics in 
the United States. Left panel: Displays the increase of percent incidence of MRSA, VRE and 
FQRP vs. time in years. Right panel: Displays the declining number of approved antibiotics vs 
time in years. Figures were reproduced from the Infctions Disease Society of America, Bad 
Bugs, No Drugs website: http://www.idsociety.org/badbugsnodrugs.html 
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Targets and Mechanisms of Antibiotic Resistance 
 
Antibiotics are able to function and kill bacteria by inhibiting enzymes and 
proteins that are necessary for their survival. Ideal antibiotics have low affinity for 
host enzymes and proteins and have low toxicity levels within hosts. Four major 
categories of targets into which most antibiotics can be classified are inhibitors of 
cell wall synthesis, nucleic acid synthesis, protein synthesis and agents that impair 
the cell membrane[7]. Specifically for protein synthesis, antibiotics can bind to the 
50S and 30S subunits of ribosomes preventing the translation of RNA to protein. 
Nucleic acid synthesis can be blocked three ways: antibacterials can inhibit RNA 
polymerase, which is needed to initiate transcription; antibacteril agents can act 
by inhibiting folic acid biosynthesis, which stops the formation of folate that is 
required to synthesize DNA bases; and lastly can prevent DNA topoisomerases 
(including DNA gyrases) from functioning, which renders the enzyme incapable 
of catalyzing the supercoiling of DNA necessary for metabolic processes[7]. 
Figure 1.3 illustrates the possible targets of antibiotics, as well as lists common 









Since antibiotics function by inhibiting necessary processes within 
bacteria, in order to survive, bacteria must find means of bypassing the inhibition 
capabilities of antibiotics. Therefore, bacteria exhibit three phenotypes in relation 
to antibiotics: susceptibility, intrinsic resistance and acquired resistance. Any 
bacteria species that is susceptible to an antibiotic may develop or acquire 
resistance to that antibiotic, either through de novo mutations or the inheritance of 
DNA encoding resistance either from transformation or mobile genetic elements 
(including plasmids and transposons)[4]. Intrinsic resistance refers to a bacteria’s 
natural ability to be resistant to an antibiotic due to the make up ofthe organism, 
meaning the hydrophobic lipopolysaccharide outer membrane of gram-negative 
bacteria repel hydrophobic antibiotics and large compounds cannot transverse th  
Figure 1.3 Targets of antibiotics with representative agents. The various targets of 
antibiotics are highlighted in yellow. A few representative antibiotics are listed for each 
target. This figure was reproduced from Molecular Biology of the Cell, 4th ed., Ch. 25, fig. 
8 . [8] 
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size-excluding porins in the outer membrane[9]. Basically, no genetic 
manipulations are needed for intrinsic resistance. On the other hand, acquired 
resistance, which is present in only select isolates of certain species, exhibit 
resistance to antibiotics through four mechanisms, which are alteration of the 
antibiotic through enzymatic degradation or modification, acquisition of a drug-
insensitive enzyme that functions in place of the drug-sensitive enzyme thus 
altering the metabolic pathway, decreased accumulation of the antibiotic through 
reduced membrane permeability and/or increased efflux and mutation of the target 
site rendering the antibiotic unable to bind its target[7] (Figure 1.4).  
Due to the fact that acquired resistance requires resistant genes from 
exogenous DNA, either from transformation or mobile genetic elements, or de 
novo mutations, a mechanism for incorporating these genes or inducing mutations 
is necessary. RecA, a recombinase protein, has been implicated in the acquisition 
and incorporation of bacterial resistant genes[19, 23-27] and through the induction of 











Mechanisms of Chloramphenicol Resistance 
 
Chloramphenicol was first announced in 1948 by Ehrlich and 
coworkers[10]. What made this antibiotic so unique is it was the first natural 
product to contain a nitro group and to be a derivative of dichloroacetic aid[11]. It 
is mainly a broad-spectrum bacteriostatic agent with the ability to inhibit all 
bacteria tested and organisms that are closely related to bacteria[11]. 
Chloramphenicol inhibits protein synthesis in concentrations of 10 µM and above, 
but does not inhibit the activity of proteins[11]. During protein synthesis, 
aminoacyl tRNA molecules are synthesized in the cytoplasm and are transported 
Figure 1.4 Antibiotic resistance mechanisms. The four major mechanisms or resistance 
are outlined: mutation or over production of the target, altered metabolic pathway, 
degradation or alteration of the drug or decreased drug accumulation due to reduced 
membrane permeability and/or active efflux pumps.  
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to the ribosome where they bind to associated mRNA at the P site[7]. Another 
tRNA then binds to the A site that corresponds to the next codon in the mRNA 
sequence and a transpeptidation reaction utilizing peptidyl transfese allows for 
the linkage of the growing peptide chain to the next amino acid to be add d to the 
chain in the A site[7]. Lastly, the growing chain translocates to the P site, which 
frees the A site for the next tRNA and this will continue until a stop codon is 
reached[7] (Figure 1.5). Specifically, chloramphenicol inhibits protein synthesis by 
binding to the 50S ribosomal subunit of the 70S ribosome and impedes the 








Three of the common mechanisms of antibiotic resistance have been 
implicated in the development of chloramphenicol resistance: 1) reduced 
accumulation of chloramphenicol in the cell through reduced membrane 
permeability and active efflux pumps[9,12-14] 2) altered target[15] and 3) enzymatic 
degradation of chloramphenicol[7,17]. Chloramphenicol, being a small and 
Figure 1.5 Protein synthesis. Image was reproduced from the Biology Active 
Learner, 6th ed. website: http://www.dwm.ks.edu.tw/bio/activelearner/index.html 
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hydrophilic antibiotic, transverses the outer membrane through porin channels,[9] 
which span the outer membrane and are water-filled open channels that allow he 
passive diffusion of hydrophilic molecules[12]. The three major porins of E. coli 
are the OmpF, OmpC and PhoE porins and E. coli exhibits modifications of its 
porins to become resistant to antibiotics by reducing the amount of OmpF and 
OmpC porins or mutating OmpC porins[12]. This kind of mutation involves the 
alteration of the internal loop 3, which in return alters the ability of antibiotics to 
transverse the porin channels[12]. Chloramphenicol is believed to pass through the 
OmpF channel due to its larger size and because of its expression being regulated 
by marA, which is de-repressed in response to chemical and antibiotic stress and 
through downstream signaling, porin synthesis is downregulated while efflux 
pumps are overexpressed[9,12-13]. Figure 1.6[13] outlines this cascading event. The 
AcrAB-TolC is a common efflux pump used to export commonly used antibiotics, 
chloramphenicol included[13,14,15]. The acrA gene encodes a membrane fusion 
protein, acrB encodes a cytoplasmic membrane efflux pump and tolC encodes for 
an outer membrane channel[13,14]. MdfA (also known as CmlA and Cmr) is 
another multi-drug pump that is chromosomally encoded and it provides 
resistance to chloramphenicol[13,15].  
Also reported, a mutation of guanine to adenine at position 2057 of the 
23S RNA gene in the rRNA operon confers resistance to chloramphenicol[16]. 
This mutation causes an alteration in the sequence in a region of the 23S 
secondary structure, which is a part of the peptidyl transfera e region, and 
therefore hinders chloramphenicol to bind the 50S subunit due to the peptidyl 
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transferase active site being located near the peptidyl transfe se region 
containing the 23S RNA region[16]. Thus, alterations of the target site of 





Lastly, genes that are responsible for enzymatic degradation of 
chloramphenicol are cat genes, which encode for chloramphenicol 
acetyltransferase[7,18]. This enzyme functions by acetylating the hydroxyl group on 
 
Figure 1.6 Signaling cascades responsible for loss of porins and increased drug efflux. 
Activation of marA through de-repression of marR due to antibiotic induced stress activates 
micF, which inhibits ompF expression, and activates acrA, acrB and tolC, genes that express 
proteins necessary for the assembly a common efflux p mp in E. coli. This figure was 
reproduced from13]. 
 13
position three on the carbon side chain, utilizing an acetyl group from acetyl-
coenzyme A, giving rise to the 3-acetyl derivative; the acetyl group can replace 
the hydroxyl group on the carbon on position one on the carbon side chain, thus 
allowing for a second acetylating reaction to the hydroxyl group on the third 
carbon on the side chain[7,17,18]. Some of the cat genes found in E. coli include 
catI, catB2, catB3[18], which encode for different types of CATs (types A and B, 




The Functions of the RecA Protein 
 
Genetic preservation and variation are two necessary processes all living 
organisms must utilize and balance in order to survive. The genome must be 
preserved in order for an organism to function properly while it also must be 
varied in order for organisms to adapt to changing environments. RecAis a key 
player in maintaining the balance in bacteria: all bacteria contain RecA and its 
function is implicated in processes that lead to either genomic preservation or 
variation[19, 20]. Metabolic and physiological stresses caused by antibiotic 
treatment, heat shock, starvation, exposure to UV or harmful chemicals and 
pressure changes either directly or indirectly lead to DNA damage, which 
effectively activates RecA[19,21]. 
Within the cell, RecA exists as a protein monomer and is biologically 
inactive; however, in the presence of ssDNA and ATP, RecA monomers 
polymerize to coat the ssDNA to form an activated RecA nucleoprotein filament 
(NFP) and begin ATP-hydrolysis driven DNA repair processes[19,23], which 
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included homologous recombination and replication for restart[23], as well as 
signaling the initiation of the SOS response[22]. RecA-mediated repair processes, 
whether they initiate preservation or variation of the genome, aid in the survival 
of bacteria by providing means of maintaining genetic integrity as well as 
adapting to environmental changes. Figure 1.7 summarizes the activities of RecA 



















Figure 1.7 Signal-like and motor-like activities of RecA. Upon activation of 
the RecA-NPF, RecA-mediated activities that lead to genomic preservation are 
SOS induction translesion synthesis, replication for restart and recombination 
DNA repair, while activities that lead to genomic variation are error-prone DNA 
synthesis and homologous recombination. 
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The Involvement of RecA in Recombination 
 
Recombination in its simplest meaning is the breaking and rejoining of 
genetic materials, most often DNA. It is implicated in the genetic diversification 
of offspring during sexual unions and horizontal gene transfer between 
microorganisms. Homologous recombination, or genetic exchange between 
similar or identical strands of DNA, is needed for recombinational repair in 
bacteria. However, recombinational repair is only implicated in certain types of 
DNA damage due to DNA being double stranded; for example, lesions occurring 
on one strand can easily be excised and the other strand can be used as a t mplate 
to fill in the gap, which does not require recombination[19]. Cross-links, double-
strand breaks and lesions in ssDNA would be cases of DNA damage th t would 
require recombination to obtain reliable sequence information from a homologous 
strand and RecA is at the heart of recombinational activity[19].  
During each of the three repair mechanisms mentioned, ssDNA is either 
exposed (stalled replication forks caused by lesions) or generated by the actions of 
other accessory proteins (UvrA,B, and C and nucleases in cross-link repair and 
RecBCD and nucleases in double-strand break repair)[19]. Once ssDNA is present, 
RecA polymerizes on the ssDNA to form the NPF[19,23], conducts a homology 
search by recruiting a linear dsDNA molecule, then aligns the ssDNA with a 
homologous sequence of dsDNA[23] and proceeding to facilitate strand 
exchange[24]. Combined with RuvA,B and C, branch migration occurs, which 
eventually leads to resolved, repaired dsDNA[25]. Figure 1.8 summarizes the role 







Not only is this process useful for DNA repair, bacteria can utilize RecA-
mediated homologous recombination to incorporate genes into their genome that 
they acquired through horizontal gene transfer[26]. Horizontal gene transfer can 
occur in three ways: transformation, transduction and conjugation[27] (Figure 
1.9[27]).  Transformation is the process in which bacteria uptake exogenous DNA 
from their environment, usually excreted by a donor bacteria during lysis (usually 
upon death of the bacteria). Transduction occurs through a bacteria phage, which 
carries the genes from the phage-infected donor cell to the recipient cell and 
injects the DNA into the recipient cell. Conjugation is the process by which donor 
bacteria assemble a sex pilus (F factor) and inject DNA into the recipient cell. 
Once bacteria cells have taken up the exogenous DNA, whether from the same or 
Figure 1.8 Role of RecA in homologous recombination. RecA polymerizes onto ssDNA 
formed during stalled replication forks, cross-link repair and double-strand break repair. 
RecA then performs a homology search of dsDNA and pairs the ssDNA with homologous 
sequences. RecA then performs strand invasion and RuvA,B and C drive branch 
migration, which leads to repaired dsDNA and the restart of replication forks. Figure was 
adapted from Roca and Cox, Prog Nucleic Acid Res Mol Biol 56, 129-223[19] 
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different species, RecA can pair this DNA, which is heteroduplex DNA, with 
homologous ssDNA from the host cell (Figure 1.10). Through strand exchange 
during a tsDNA intermediate, genes from the donor bacteria can be incorporated 
into the genome of the host cell. This process has had tremendous effect on the 






Figure 1.9 Horizontal gene transfer in bacteria. This figure displays the 
three mechanisms for HGT: transformation, transduction and conjugation 







The Role of RecA in the SOS Response to DNA Damage 
 
RecA has proven to be a vital participant in genomic preservation in 
bacteria by playing a key role in homologous recombination to repair DNA19,23] 
that has experienced a stalled replication fork, double-strand break or cross-
linkage, as well as in the diversification of the bacterial genome through a partial 
“mutagenic” role utilizing homologous recombination to incorporate genes 
acquired during horizontal gene transfer[26,27]. Yet another vital role of RecA in 
Figure 1.10 Homologous recombination during horizontal gene transfer. In this case, the 
homologous dsDNA was donated from a donor cell. Thehost cell acquires that DNA and can 
use it to pair its own ssDNA to homologous sequences in the acquired donor DNA. When this 
happens, a tsDNA intermediate is formed, during which RecA can perform strand exchange, 
which eventually leads to resolved dsDNA incorporating genes from the donor. 
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genomic preservation and variation is through induction of the SOS 
response[21,22].  
The expression of SOS genes are regulated by LexA, a repressor protein 
dimer, which binds to the SOS box of the promoter region of the SOS genes, thus 
preventing their expression by preventing RNA polymerase from accessing the 
promoter[22]. When cells are experiencing normal physiological conditions, the 
SOS genes are repressed by LexA. However, when DNA damage occurs and 
ssDNA accumulates, RecA polymerizes on the ssDNA and is activated, which in 
return interacts with the LexA repressor protein[28,29,30]. This interaction with 
LexA facilitates the autoproteolysis of LexA, thus allowing the downstream DNA 
repair proteins to be turned on[28,29].  It is important to note that the induction of 
the SOS to genomic damage is a graded response in which different mechanisms 
of repair are sequentially activated, starting with excision repair and 
recombination and eventually leading to mutagenesis if the damage persists 
(Figure 1.11). Sequential activation of approximately forty DNA repai  roteins 
depends on the location of the genes to their specific SOS box and the binding 
affinity of LexA to that SOS box[22]. Generally, proteins can be classified into 
three main groups: early, middle and late genes.  
Early genes consist of uvrA, B, C and D, which encode for endonucleases 
that participate in nucleotide excision repair[31]. Small amounts of DNA damage 
can be repaired this way by simply excising a small length of ssDNA containing 
the damage and this process allows the cell to attempt to repair the damage 
without fully committing to full-fledged SOS response.  
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However, if the damage is not repaired after a short amount of time, he 
amount of de-repressed LexA increases, thus allowing for the expression of the 
middle SOS genes, which include r cA and recBCD[32,33], the genes required for 
the expression of recombinase proteins used in double-strand break and cross-
linkage repair. Much larger amounts of DNA can be repaired through 
recombination as compared to nucleotide excision repair. Because RecA is 
included in the group of middle SOS genes, the SOS response can be propagated 
at a very accelerated rate due to the influx of RecA expression.  
DNA damage that still persists even after NER and recombinational repair 
attempts will eventually lead to the activation of the late SOS genes, which 
encode for Polymerase IV, UmuC and D, as well as SulA[22,35]. SulA is 
responsible for binding FtsZ, an essential protein that initiates cell division[34]. By 
binding FtsZ, cell division is arrested, thus diverting all of the cell’s efforts to 
repairing the damage. This includes the atuoproteolysis of UmuD whose 
byproducts can bind to UmuC, therefore forming Polymerase V[22]. Both 
translesion Polymerases IV and V lack the ability to proof read DNA and 
therefore cannot detect lesions within the DNA, thus allowing the insert on of any 
base into gaps across from the site of the lesion[22, 35]. And thus SOS mutagenesis 
is induced, which allows for the introduction of spontaneous mutations that can 














Responsibility of RecA in the Development of  
Resistance to Antibiotic Treatment 
 
RecA has profound roles in the repair of DNA through homologous 
recombination and also in inducing the SOS response in bacteria by signaling for 
the expression of DNA repair proteins, which both processes are imperative in 
maintaining bacterial genomic integrity. RecA-mediated homologous 
recombination is also used by bacteria to incorporate genes acquired through 
horizontal gene transfer by pairing the heteroduplex DNA from the donor cell 
with homologous ssDNA from the host cell, which leads to integration of the 
donated DNA into its own genome. SOS induction by RecA can also lead to SOS 
mutagenesis as a last resort when nucleotide excision repair and recombination 
Figure 1.11 Bacterial SOS response. The induction of the SOS to genomic damage is a 
graded response in which different mechanisms of repai  are sequentially activated after 
the de-repression of the LexA repressor protein, starting with excision repair (UvrA, B, C 
and D) and recombination (RecA and RecBCD) and eventually leading to mutagenesis if 
the damage persists (SulA repression of FtsZ, UmuC and D for translesion synthesis). 
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fail to repair DNA damage. SOS mutagenesis and homologous recombination of 
horizontally acquired genes are therefore essential processes for genomic 
variation, which provide mechanisms for bacteria to survive in changing 
environments.  
Antibiotics severely alter the environment of bacteria, thus imposing great 
stress on the bacteria to survive. Antibiotic induced stress has been shown to 
induce the SOS response through RecA activation[4,26]. As shown in Figure 1.3, 
there are six major types of antibiotics categorized by their targets: protein 
synthesis inhibitors, RNA polymerase inhibitors, inhibitors of DNA synthesis and 
function, inhibitors of cell wall synthesis, agents that disrupt cell membrane 
integrity and folic acid biosynthesis inhibitors. Besides DNA damaging agents, 
other antibiotic classes that have been shown to activate the SOS response are 
folic acid biosynthesis inhibitors (since folate is needed for the synthesis of 
nucleic acids) and inhibitors of cell wall synthesis. It is also pertinent to classify 
antibiotics according to their mechanism of action: either bacterios atic (inhibiting 
cell growth) or bactericidal (killing > 99.9% of bacteria). Bacteriostatic agents 
mostly consist of protein synthesis inhibitors.  
Recently, it has been demonstrated that all classes examined of 
bactericidal agents including quinolines, β-lactams and aminoglycosides, produce 
hydroxyl radicals in E. coli through the reduction of hydrogen peroxide by ferrous 
iron, which contribute to the killing action of these antibiotics, thus indicating that 
there is a common mechanism that induces cellular death[36]. However, 
bacteriostatic agents do not produce these radicals. Specifically, this process was 
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proposed to occur by bactericidal agents stimulating the depletion of NADH by 
hyperactivation of the electron transport chain, which in return stimulates 
formation of superoxide that damages iron-sulfur clusters. Iron releas d from 
these clusters is oxidated, giving hydroxyl radicals as by products tha  damage 
DNA, lipids and proteins, ultimately leading to cell death[36]. As expected, the 
SOS response was also stimulated via RecA, as demonstrated by a fluorescence 
assay measure LexA-driven GFP expression and a cellular assay monitoring cell 
death in wild type and ∆recA cells. In the fluorescence assay, quinolines and β-
lactams showed a significant increase in the GFP reporter, thus indicating the 
activation of RecA and the SOS response[36]. Kanomycin, the aminoglycoside 
tested, did not show an increase in the GFP reporter, but this is expect d since 
kanomycin blocks translation of proteins and therefore the translation of GFP 
expression. By disabling the SOS response, the killing effect of bactericidals 
would be expected to increase. This was demonstrated with all three agents in 
∆recA cells, which stresses the importance of the induction of the SOS response 
to bypass the killing effects of hydroxyl radicals[36]. 
The results from the Collins group also suggest that bacteriostatic agents, 
since they do not produce hydroxyl radicals, may not induce the SOS response. 
Experiments to prove this were not done in this study. However, as demonstrated 
by our laboratory (unpublished data), studies done with chloramphenicol (a 
bacteriostatic agent) show that at sub-lethal dosages of chloramphenicol, wild 
type E. coli cells develop resistance to chloramphenicol at a slower rate then E. 
coli cells with RecA constitutively turned on in cultures (Figure 1.12, top panel) 
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and relativly at the same rate during passaging (Figure 1.12, bottom panel). E. coli 
cells with RecA knocked out are not able to develop resistance in culture to 
chloramphenicol at sub-lethal dosages (Figure 1.12, top panel) and developed 
resistance much more slowly during passaging (Figure 1.12, bottom panel). These 




Figure 1.12 Development of chloramphenicol resistance in wild type, super RecA and ∆recA-
∆lexA E. coli cells. The top panel shows resistance development to chloramphenicol at 5 µg/mL in 
super RecA and wild type cells in the one-flask resistance assay. The bottom panel shows the results of 
a passaging assay: after 8 passages lasting 24 hrs. each, wild type and super RecA cells develop 
resistance at relatively the same rate while there is a lag in resistance development in ∆recA cells. 
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The Griffith Experiment: 
Potential Role of RecA in Incorporation of Exogenous DNA 
 
In the 1920’s, pneumonia was a prevalent cause of death, which is an 
infectious disease affecting the lungs and is caused by a bacterial species 
Streptococcus pneumoniae, or pneumococci. Dr. Frederick Griffith, while 
studying the distribution of different pneumococcal types obtained frompeople 
infected with pneumonia, noticed four distinct types: Types I, II and III and 
Group IV. Upon compilation of the data of two two year periods and one thre
year period, he discerned a decrease in the number of Types I and II pneumococci 
infections and a significant increase in the incidents of Group IV infections[37]. 
However, it was also noted that Group IV pneumococci was always found in 
conjunction with another type and was not shown to cause the disease on it ow . 
Therefore, Griffith devised a series of experiments involving the injection of these 
strains into mice in various combinations of the types in heat-killed virulent, or 
smooth (S), versions of the strains with living avirulent, or rough (R), versions of 
the strains to see if reversion of the R strain to S form could ccur. It is also 
important to note, what defined the S strain from the R strain was a mucous film 
around the S strain, which was a polysaccharide capsule, referred to as S antigen 
by Griffith[37]. The polysaccharide capsule protects the pneumococci from attack 
by the immune system of its host. What he observed was mice injeted with an S 
strain alone died of pneumonia while mice injected with a R strain alone lived and 
did not produce R or S cultures when obtained from blood of the mice[37]. Also 
dually noted, when mice were injected with only heat-killed S strains, the mice 
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also lived and did not produce either S or R cultures when obtained from blood of 
the mice.  
But perhaps the most significant observations of this study when mice 
were injected with both R and heat-killed S strains were five fold: 1) the mice 
died of pneumonia 2) cultures recovered from the blood of the mice were S strains 
3) inoculation of the mice of the R strain of on type of pneumococci and the heat-
killed S strain of a different type of pneumococci displayed the typ of the heat-
killed culture 4) the most successful reversions of the R strain to the S strain were 
the inoculation with same type of pneumococci (for example, Type II R and heat-
killed Type II S) and 5) reversion is not observed when incubated in vitro, 
meaning passage through mice is necessary for the reversion[37]. From these 
results, it can be concluded that the R strain is able to make use of the remnants of 
the dead S culture for the synthesis of S antigen. It can also be hypothesized that 
since this only occurred in mice and not in vitro that the pressure of the immune 
system is needed to drive the R strain to survive and seeks the information on how 
to make S antigen from the killed S cells. 
Precisely how transformation occurred from the R strain to the S form was 
elucidated by Avery, MacLeod, and McCarty. In their attempts, theyused the 
R36A strain, which was an R Type II pneumococci strain, which was derive  
from an S Type II strain that had its capsule removed[38]. Crude extracts were 
obtained from the S strain (A66, Type III pneumococci) by washing with saline 
after they were killed with heat and was purified by appropriate methods[38]. 
These extracts were subjected to treatment with trypsin, chymotr psin and 
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ribonuclease and when these extracts were used to transform the Rstrain, 
transformation to the S form was observed[38]. Therefore, it can be concluded that 
proteins and ribonucleic acid, normally broken down by these substances, are not 
responsible for transformation. But when the extracts were subjected to treatment 
with deoxyribonucleases from various sources, the transformation activity of the 
R strain to the S form was obliterated[38]. Finally, it was demonstrated that DNA 
was responsible for the transformation principle.  
Since DNA is responsible for transformation, the cell must have a m thod 
of uptake and incorporation of virulent genes in the case of pneumococci studies 
by Griffith and Avery et al. In the case of this particular study, a method for the 
incorporation of resistant genes is necessary. Exogenous DNA is taken up by the 
cell and once ssDNA is present, RecA is activated and forms the nucl oprotein 
filament with the ssDNA[19]. From here, RecA will facilitate recombinational 
repair and integration of the exogenous DNA into the host genome. This process 
was necessary for the R strain of the pneomococci to incorporate the DNA 
encoding for the polysaccharide capsule from the heat-killed S strain, thus making 
it virulent. This principle can be applied to cultures of E. coli inoculated with 
heat-killed antibiotic resistant cells. Theoretically, if E. coli can demonstrate 
natural competence as S. pneumoniae does (either by a similar or unique 
pathway), then E. coli cells should be able to uptake the exogenous DNA 
encoding antibiotic resistance genes and incorporate it into its own genome 
through the use of RecA mediated recombination.  
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Observation of Natural Competence in Escherichia coli 
 
Competence, the ability of a cell to take up exogenous DNA from its 
environment, can be classified as artificial or natural. Artificial induction of 
competence is a standard laboratory technique in recombinant DNA technology 
and is used to incorporate desired genes into host cells[39]. It involves the use of 
ice-cold CaCl2 or other divalent cations, which is necessary to fluidize the 
membrane (cold temperature) and aid DNA adsorption and binding to the cell 
surface by forming coordination complexes with DNA and the LPS (Ca2+); a brief 
heat shock that causes the membrane to become rigid, allows for the release of 
lipids, which possibly forms pores for DNA to enter and mediates the 
depolarization of the membrane, therefore reducing its negative charge inside the 
cell allowing DNA to pass into the cell; and incubation on ice thatallows the 
pores to close and trap the DNA[39].  
Natural competence, on the other hand, is a cell’s natural ability to take up 
exogenous DNA from the surrounding medium. Genetic transformation through 
the utilization of natural competence involves four steps: (1) developmnt of 
competence through a stimulus; (2) binding of DNA to the cell surface; (3) 
processing and uptake of the DNA and (4) integration of the DNA into the 
chromosome by recombination and expression[40]. Problems that arise from the 
translocation of DNA are hydrophobic bacterial cytoplasmic membranes act as 
barriers for DNA, the outer membrane of gram-negative bacteria (like E. coli) is 
negatively charged due to the LPS content and hinders negative molecules like 
DNA from crossing the outer membrane and nucleases in the periplasm c space 
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may attack DNA during transfer. However, certain strains of gram-positive and 
gram-negative bacteria have means of uptaking DNA and protecting it while it 
transverses. For example, Bacillus subtilis forms a pilin complex with ComGC 
proteins (competence proteins), allowing the DNA-binding protein complex 
ComEA to bind DNA, which delivers the DNA to a nuclease (unidentified) for 
degradation of one strand of the DNA and the compliment strand is driven into 
the cytosol by a DNA translocase complex, ComFA, through a channel in the 
cytoplasmic membrane constructed from ComEC proteins[41]. S. pneumoniae has 
a very similar mechanism. An example of a gram-negative bacteri  natural 
competence pathway is N. gonorrhoeae, which consists of a pilin complex of PilQ 
proteins that bind DNA and allow it to cross the cell surface[41]. Another pilin 
complex consisting of PilE allows the DNA to cross the periplasm with the aid of 
ComE, a DNA-binding protein, and a nuclease at the cytoplasmic membrane 
degrades one strand while allowing the other strand to enter the cell through a 
channel consisting of ComA proteins[41]. Figure 1.8 demonstrates this[41]. Claverys 
and Martin also demonstrated that there are some homologous proteins in E. coli 
to DNA uptake machinery proteins and pore assembly proteins found in other 
species[41], which suggests that E. coli may just be naturally competent, contrary 
to popular believe. 
Other authors have demonstrated convincing evidence that E. coli is 
naturally competent. Maeda et al. showed that when colonial SURE E. coli cells 
(kanr and tetr) grown on various solid media (including LB, water, and CaCl2 gar, 
as well as food stuffs) harboring kanomycin and tetracycline werintroduced to a 
 30
pBluescript KS- plasmid (ampr) were re-grown on solid media harboring all three 
antibiotics (kan, tet and amp), the cells were able to grow[42]. These results 
indicated that E. coli colonies on various solid medias can develop moderate 
competence, as well as that this process was either Ca2+ independent or trace 
amounts of Ca2+ from the agar or dead cells could act as competence inducing 
factors. Maeda and collaborators also further demonstrated this possibility by 
utilizing conjugative deficient strains of E. coli, CAG18439 harboring tetr and 
DH5a harboring the pHSG299 plasmid with kanr, to co-culture them on LB, water 
or CaCl2-agar lacking antibiotics then transferring colonies to LB, water or CaCl2-
agar containing both antibiotics[43]. Since colonies grew, it can be concluded that 
nonconjugative, nonviral horizontal gene transfer is possible in E. coli, which 
would indicate the need for natural competence.  
Baur et al. also have contributed some convincing evidence that E. coli is 
able to develop natural competence. JM109 cells were incubated in various 
natural waters in which the Ca2+ concentrations were known and pUC18 plasmid 
DNA was added to the culture, which encoded for ampr[44]. After sufficient 
incubation, samples were plated on LB-amp-agar plates and the transformation 
frequencies were determined[44]. The results showed a positive correlation 
between the calcium concentrations of the waters and the transformati n 
frequency (meaning as the calcium concentration increased, so did the 
transformation frequency)[44]. What these results demonstrated was calcium 
concentrations exceeding 1 mM, concentrations associated with natural waters, 
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are sufficient to induce competence in E. coli without the addition of any other 
competence-inducing factor.  
Lastly, Sun et al. observed natural transformation in E. coli without the aid 
of cations and temperature shifts[45]. In shaking cultures of HB101 E. coli cells, 
cultures were incubated for 12 hours and statically cultured for up to 12 hours. A 
plasmid harboring ampr (pDsRED) was added and mixed into the cultures at 
various incubation times, which were then plated on LB-amp-agar and the 
transformation efficiency was determined[45]. The transformation efficiency was 
shown to be dependent on time in static culture, not on viability, cations or 
temperature shifts.  
Much more research has been conducted in this area, but significant works 
were summarized above. This work is important because it demonstrates the 
possibility that Griffith’s transformation principle can be applied to cultures of E. 
coli.  The work presented here demonstrates that antibiotic resistant genes can be 
horizontally transferred between E. coli cells and they are capable of taking up 
exogenous DNA from their environments (plasmids, for example), which implies 
that DNA released from dead cells, especially heat-killed cells, can be transferred 











Previous Efforts to Develop RecA Inhibitors  
 
RecA-mediated activities, including the induction of the SOS response and 
homologous recombination through strand exchange, have been implicated in the 
spread of horizontally transferred antibiotic resistance genes ad de novo 
antibiotic resistance development, therefore making RecA a unique targ t for 
inhibiting the spread of antibiotic resistance. However, few inhibitors of RecA 
had been revealed as of a few years ago. Since then, other members of the 
Singleton laboratory have had the opportunity to unearth inhibitors of RecA, 
including metal complexes, ATP analogs, peptides and small molecules.  
In collaboration with the Kohn laboratory at the UNC Eshelman School of 
Pharnamcy, Dr. Andrew Lee had the opportunity to test Zn2+, Hg2+, Cu2+, Ca2+, 
Figure 1.13. Natural competence and DNA entry into the cell of gram-positive vs. 
gram-negative species. a) N. gonorrhea, representative gram-negative bacteria. b) B. 
subtilis, representative gram-positive bacteria. This figure was reproduced from Claverys 
et al. (2003) TRENDS in Microbiology, 11 (4), 161-165[41]. 
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Ba2+, Mn2+, Co2+, Ni2+, Ag+, Cd2+ and Bi3+ metals for inhibition of the RecA 
protein. The reason for choosing metal complexes was due to the discovery of 
Kohn’s laboratory in that the Rho protein was inhibited by Be2+, Cd2+, Ni2+, Zn2+ 
and Bi3+ metal cations complexed with dithiols[46-48] and due to the fact that Rho 
is functionally and structurally homologous to RecA[49]. Metal complexes that he 
was able to show had inhibitory effects on RecA were Zn2+, Hg2+, Cu2+, Ag+, Cd2+ 
and Bi3+, which in a light-scattering assay[46-48] displayed aggregation of RecA in 
vitro.  After extensive investigation into bismuth-dithiols, Bi3BAL in particular, it 
was shown that Bi3BAL was able to irreversibly inactivate the RecA protein, but 
did not do so through competing with ATP or ssDNA (results submitted for 
publication). Thus, it is a promising lead compound for future inhibitors. 
Another means of inhibiting RecA activity explored in the Singleton 
laboratory is the use of small peptide inhibitors that are rationally designed to 
interrupt the monomer-monomer interface of two RecA molecules, which would 
essentially disrupt the assembly of the RecA-DNA filaments[50]. Based on the N-
terminal domain of RecA, the peptides INPEP and INPEP-SH (INPEP with a salt 
bridge) were designed to bind more tightly than another RecA monomer[50]. The 
IC50 value of ATP hydrolysis was lowered to 35 µM with INPEP and 30 µM, a 
20-fold decrease as compared to the N-30 peptide modeling the N-terminus[]. By 
conjugating a cysteine residue on INPEP-SH with 2-thiopyridine to yield INPEP-
STP, the IC50 was decreased to 3 µM, thus resulting in a very potent 29mer 
peptide inhibitor of RecA filament assembly and therefore attenuaing RecA-
mediated ATP hydrolysis and DNA binding [50].  
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Since the activity of RecA is dependent upon the formation of the 
nucleoprotein filament, a process that requires the hydrolysis of ATP to tightly 
bind ssDNA[51,53,54],  seeking analogs of ATP that could potentially bind the active 
conformation of RecA to competitively inhibit hydrolysis or bind the inactive 
conformation of RecA to promote the dissociation of ssDNA[42] could hinder the 
recombinational capabilities of RecA. In a study done by Wigle, Le and 
Singleton, it was shown that out of twenty-eight potential ligands of RecA 
consisting of general nucleotide triphosphates (NTPs) and nineteen synthetic 
analogs previously untested, six analogs were able to attenuate the DNA-
dependent NTPase activity of RecA[52]. Substitutions that prevented RecA from 
using the analogs as substrates, and therefore attenuating NTP hydrolysis, were 
summarized as follows: (1) substitution of groups larger than a hydrox l group 
(OMe, for example) on the C2’ position of the ribose ring prevented ATP and 
UTP from acting as substrates; (2) adding a methyl or propynyl group on the C5 
position of the pyrimidine NTPs; (3) substitution of aromatic groups larger than a 
benzyl ring on the N6-amino group on the adenine ring[52]. Others were shown to 
be modest substrates of RecA.  
Although nucleotide analogs are able to inhibit ATP hydrolysis of RecA, 
they were not suitable for cellular assays and therefore, othermeans of inhibition 
were sought out, which included screening of small molecules of a focused set of 
commercially available compounds[55] and high-throughput screening of a 35,780 
compound library at the Biomanufacturing and Research Institiute and 
Technology Enterprise located at North Carolina Central University (unpublished 
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work). From the focused set of commercially available compounds, ATP
hydrolysis by RecA was monitored with a fluorescent ATP assay involving the 
oxidation of horseradish peroxidase to resorufin as A595
[].  Five groups of 
compounds were tested: (1) vanillin, cinnamaldehyde, curcumin, genistin and 
genistein, which were shown to be active in other biological assays;[56-59] (2)  
adenosine nucleotide-like compounds[60,61]: PMPA, 5’-ASBA and methotrexate; 
(3) compounds that inhibit the gyrase-Hsp-90-like family of ATPases[62,63]: 
radicicol, novobiocin and coumermycin; (4) adenine-like inhibitors known to 
inhibit protein kinases[64,65]: PP2 and PP3; (5) inhibitors of purine nucleotide 
receptors that are non-nucleotides[66]: PPADS, Bis-ANS, suramin, Congo Red and 
ANS. The only compounds from this study that were able to inhibit RecA ATPase 
activity were three suramin-like agents from group 5: Congo Red, suramin and 
Bis-ANS[55]. Suramin was also shown to inhibit DNA three strand exchange at 
100 µM [55]. 
Lastly, the results of they high-throughput performed at the BRITE center 
utilized a PMB ATPase fluorescence assay to measure the hydrolysis of ATP by 
RecA by measuring the interaction of inorganic phosphate with molybdate to 
form a phosphomolybdate blue complex, which can be measured at A650 
(unpublished data). Of the 35,780 compounds screened, seventy-three were 
reported as hits and were classified into five compound classes. From the first 
compound class, one compound, termed A1, has proven to be a potent inhibitor of 
RecA in vitro (IC50 of 8 ± 1 µM), attenuated SOS induction in a GFP-
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fluorescence cell based assay in conjunction with ciprofloxacin nd inhibited the 
RecA-mediated DNA three strand reaction (see Wigle dissertation for results).  
 
Specific Aims of This Thesis 
 
As demonstrated by Dr. Tim Wigle, the compound A1 has proven to be a 
favorable potential inhibitor of RecA, and therefore a means of attenuting the 
transfer of antibiotic resistant genes. Therefore, the specific aims of this thesis are 
as follows: (1) demonstrate that the addition of A1 to cultures grown in sub-lethal 
dosages of chloramphenicol prevents or slows the development of resistance of 
Escherichia coli MG1655 wild type cells; (2) apply the Griffith experiment to 
Escherichia coli MG1655 cells to observe the transfer of antibiotic resistant genes 
from heat-killed resistant cells to wild type cells; (3) demonstrate that inhibitor 
compound A1 attenuates the process of transferring antibiotic resistant genes in 
LB medium from heat-killed resistant cells to wild type Escherichia coli MG1655 
cells; (4) utilize molecular modeling methods of screening to find other potential 
RecA inhibitors based on inhibitory concentration data obtained from various 
high throughput screens.  
A1 was shown to have a half maximal inhibitory concentration of 8 ±1 
µM against the RecA protein in i vitro experiments. Therefore, utilizing a one-
flask resistance assay, monitoring the cultures of MG1655 cells should reveal if 
A1 is able to penetrate into the cells and effectively inhibit RecA. This should 
theoretically attenuate the onset of resistance to antibiotics. However, if such 
resistance mechanisms of efflux and reduced membrane permeability are utilized, 
as often seen with chloramphenicol, then inhibiting RecA may have no effect on 
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the resistance development to chloramphenicol, since mutations are not always 
needed and the SOS response is not normally induced because chloramphenicol 
functions by inhibiting protein synthesis. RecA knockout cells will serve as a 
negative control, which should not develop resistance if RecA is necessary for the 
onset of resistance and may develop resistance if RecA is not necessary. 
According to the Griffith experiment, DNA can be horizontally transferred 
from heat killed cells of a virulent strain of Streptococcus pneumoniae to an 
avirulent strain of S. pneumoniae, which results in a virulent strain that is able to 
kill mice.  Recent studies have shown E. coli to be naturally competent at a much 
lower rate than other species of bacteria, such as S. pneumoniae. Wild type E. coli 
MG1655 cells, if able to develop competence in liquid medium, would be able to 
uptake and incorporate antibiotic resistant genes when inoculated with the 
supernatant of heat killed resistant cells, therefore resulting in resistant cultures 
more quickly than cells that are grown without the supernatant of heat-kill d 
resistant cells in the presence of a sub-lethal dosage of chloramphenicol. RecA 
knockout cultures would not produce the onset of resistance or a difference in the 
rates of resistance development would not be observed.  
RecA would be required to incorporate the resistant genes into the genome 
of MG1655 cells. Since A1 has inhibitory effects on RecA, adding it to cultures 
with heat-killed chloramphenicol resistant cells would attenuate the 
recombination of the resistant genes into the genome by inhibiting RecA. 
Resistance development to a sub-lethal dosage of chloramphenicol would be 
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deterred if A1 does serve as a RecA inhibitor. Again, DrecA cells will serve as a 
negative control.   
Since A1 has been shown to be a promising candidate for inhibiting RecA 
and therefore attenuating the spread of antibiotic resistance, finding other 
compounds that can serve as inhibitors of RecA is fruitful. Also, utilizing a 
method that is cost and time effective is favorable.  Molecular modeling seemed 
to be a practical approach to finding potential compounds by minimizing time 
spent in the laboratory and the cost of experiments. By utilizing a program entitles 
Molecular Operating Environment (MOE), common scaffolds can be abstracted 
from molecules shown to have inhibitory effects against the RecA protein. The 
molecules chosen to screen were seventy-three hit compounds obtained from the 
high-throughput screen performed by Dr. Tim Wigle at the BRITE center where 
A1 was discovered. These scaffolds can be input into a search in SciFinder 
Scholar to obtain similar compounds. Hypothetically, similar compounds will 
most likely have similar chemical and biological properties. Based on this 
assumption, new potential inhibitor compounds can be obtained and tested for 









MATERIALS AND METHODS 
 
 
One-flask resistance assay reagents 
 
LB broth, purchased from Fisher Scientific, was prepared by adding 20 g 
of LB per liter of MilliQ de-ionized water. LB was distributed into 250 mL 
Erlenmeyer flasks, either 30 mL for starter cultures or 50 mL for assay cultures, 
and autoclaved for 50 min. LB-agar plates were prepared by adding 20 g of LB 
and 15 g of agar (Fisher Scientific) per liter of MilliQ de-ionized water, 
autoclaving for 20-30 min and pouring into culture plates purchased from Fisher 
Scientific.  
Chloramphenicol was purchased from Sigma-Aldrich (St. Lois, MO) and 
was prepared in 34 ng/mL 1 mL stocks in absolute EtOH. Starting materials for 
A1 were purchased from Sigma-Aldrich and A1 was synthesized by Dr. Anna 
Gromova or myself according to protocol. Chloramphenicol E-tests strips (0.016 
– 250 µg/mL) were purchased from AB-Biodisk (Piscataway, NJ). DrJim 
Collins (Boston University, Boston, MA) graciously donated MG1655 wild type 





Growing Chloramphenicol resistant cells 
Chloramphenicol resistant cells (Camr) were made by growing a 5 mL 
overnight MG1655 wt culture in LB at 37°C, inoculating 30 mL of LB with 2 mL 
of this culture and growing this culture to log phase in the 37°C shaker. Fifty mL 
of LB were then inoculated with the MG1655 wt starter culture to an OD600 of 
0.05. This culture was then grown in the presence of 5 µg/mL Cam until cells 
reached saturation (OD600 close to 2). These cells were streaked and an E-test 
(AB-Biodisk, Piscataway, NJ) was performed to ensure resistance developed 
(MIC greater than 32 µg/mL).  Cells were stored in 1 mL quantities in the -80°C 
freezer. For each assay, one or two 5 mL Camr cultures were grown at 37°C 
overnight from the freezer stock by stabbing the frozen stock and ejecting the tip 
into 5 mL of LB. To obtain heat killed supernatant, the overnight cultures were
autoclaved for 15-30 min and were cooled at room temperature until needed.  
 
One-flask resistance assay 
Culture plates were prepared by T-streaking cells from a freezer stock and 
growing them overnight at 37°C.  Overnight cultures were grown by picking 
individual colonies on the culture plate, harvesting them with a pipette tip and 
ejecting them into 5 mL of LB broth in glass culture tubes (Fisher Scientific), then 
placing them in the 37°C shaker.  Two mL of the overnight cultures were added 
to 30 mL of LB and were grown to log phase (OD600 = 0.5-0.8) in the 37°C 
shaker. OD measurements were taken in a Perkin Elmer Spectrophotometer in 1 
mL disposable cuvettes with a 1 cm path length and 600 nm wavelength.  
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While the starter cultures were growing, twelve flasks of 50 mL of B 
were prepared per cell line (wt and ∆recA) with the following conditions: (1) Cam 
only with 0, 5 and 10 µg/mL concentrations of Cam; (2) Cam and A1 with 0, 5 
and 10 µg/mL concentrations of Cam and 50 µM of A1 from a 50 mM stock in 
DMSO; (3) Cam and Camr with 0, 5 and 10 µg/mL concentrations of Cam and 1 
mL of Camr heat killed cell supernatant; and (4) Cam with Camr and A1 
containing 0, 5 and 10 µg/mL concentrations of Cam, 1 mL of Camr heat killed 
cell supernatant and 50 µM of A1 from a 50 mM stock in DMSO. When the 
starter cultures reached log phase, the assay cultures were inoculated with the 
starter cultures in each flask to an OD600 of 0.05 (about 3-5 mL of starter culture 
per flask). The assay cultures were grown in 37°C shaker and the OD600 was 
measured periodically for 120 hrs by taking 1 mL of culture out of the flasks 
utilizing sterile technique and taking measurements in the UV-Vis 
spectrophotometer.  
At OD600 of 0.6, 1 and 2, E-tests were performed on LB/agar plates. This 
is done by diluting the cells in 1 mL Epindorf tubes in LB to a fin l volume of 1 
mL to bring the concentration of the cells to an OD600 of 0.5. Cells are streaked 
with a sterile cotton swab in one direction across the plate, then are streaked in a 
90° rotation across the plate.  The E-tests are laid down in the cent r of the plate 





Molecular modeling screen 
Figure 2.1 demonstrates the general workflow for this project. Firstly, the 
original library, consisting of the 35,780 compounds from the screen done at th  
BRITE center, was narrowed down to seventy-three hit compounds using the 
PMB assay (described in detail above) termed the selected molecules. These 
molecules were grouped into a structure-data file (SDF), which is required for 
input into modeling programs. Utilizing the Molecular Operating Environment 
(MOE) program, the common scaffolds were extracted. There wer48 unique 
compounds from the 73 hit compounds (eliminating duplicates and isomers), 
which contained 7 scaffolds. Two of these scaffolds were deemed to be unique. 
Three scaffolds were used to search the literature, one unique structure and two 
structures encompassing the other unique structure, which differed in one 
aromatic ring substituent and the presence of an oxygen group on another 
aromatic substituent. These three scaffolds were searched in SciFi der Scholar 
under the substructure search feature with the conditions of organics and all 
others, single components and one or more references available in CAPLUS or 
MEDLIN. This search yielded 356 compounds (297 for the first scaffold, 33 for 
the second scaffold and 26 for the third, different scaffold).  
To represent all of the compounds searched, 92 of these compounds were 
randomly selected from the 356 compounds pulled from the literature. These 
representative compounds were converted into simplified molecular input li e 
entry specification (SMILES) format, which describes chemical structu es in short 
American Standard Code for Information Interchange (ASCII) strings, in CS 
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ChemDraw Ultra (Cambridge Software, Cambridge, MA) from the cmical 
name of the compounds. These SMILES strings were compiled into a text 
document, along with their registry numbers for easy identification, and were 
converted to a new SDF consisting of two sets of compounds: the experimental 
set (48 unique compounds) and the literature set (92 representative compounds). 
This new SDF was used to explore structure and activity space in MOE, breaking 
down each compound into its individual ligand fingerprint of bits/chemical 
fragments utilizing Tanimoto Similarity Coefficients. The Tanimoto similarity 
score is calculated with the following formula (bits are set to one when the 
chemical fragment is present in the molecules and are assigned zero when the 
chemical fragment is not present): 
 
where T is the Tanimoto score, Na is the number of bits set to one in the 
fingerprint of ligand a, Nb is the number of bits set to one in the fingerprint of 
ligand b and Nc is total number of bits set to one found in the fingerprints of both 
ligand a and b. A Tanimoto score is designated a value between zero and one with 
zero indicating no similarity and one indicating 100% similarity. A Tanimoto 
score ≥  0.7  is indicative of two molecules having high structural similarity, 
which is indicative of similar biological activity. When clustered into a heat map 
with the compounds aligned along the Y-axis and chemical fragments along the 
X-axis, compounds that are similar will be clustered around specific chemical 
fragments Black spots indicate a Tanimoto score close to one and red indicates a 
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Tanimoto score close to zero. The right hand column will give the names of the 
input structures. Seeking areas with many black spots will indicate ompounds 
that are similar in structure.  
Lastly, using AutoQSAR in MOE can predict activities based on similarity 
structures. Using the initial IC50 values of the hit compounds, the IC50 values of 
the literature compounds can be predicted based on the Tanimoto score. In order 
to perform clustering, the activities were assumed to be 0; in AutoQSAR, the 
program predicts the most probably IC50 (activity) value.  
This process can be repeated as hits are tested in the laboratory r as more 
data is compiled from other screens. The process can continually narrow down the 









PMB ATPase assay, hit validation (work done by Dr. Anna Gromova) 
The same reagents are used in this assay as the PMB ATPase ass y screen 
(see above). Each of the 7 compounds purchased were suspended in DMSO to a 
final concentration of 10 mM. In a 96-well round bottom plate (for dilutions 
only), each compound had a designated column, starting with concentrations of 2 
mM and 1.5 mM in DMSO and volume of 200 µL, and were serial diluted in 
DMSO to obtain 2 mM, 1.5 mM, 1 mM, 0.75 mM, 0.5 mM, 0.25 mM, 0.125 mM 


















Figure 2.1. General workflow.  
From the original library of 35,780, 73 hit molecules were selected. Seven common scaffolds were 
abstracted and three scaffolds (one unique and two similar) were used to search the literature 
compounds for known or commercially available compounds. Ninety-two compounds were 
randomly selected as hits and were used in conjunction with the experimental set (48 unique 
structures from 73 hits) to cluster the compounds i activity space. 
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Scientific, Los Angeles, CA), 5 µL of each dilution was added from the dilution 
plate using a multichannel pipetter to give final concentrations of 100 µM, 
75 µM, 50 µM, 37.5 µM, 25 µM, 12.5 µM, 6.25 µM and 3.125 µM of each 
inhibitor (columns 3-9). To columns 1 and 2, 5 µL of DMSO was added to each 
well to serve as positive and negative controls. Using a multichannel pipetter, to 
columns 2-9 of the assay plate, 85 µL of a cocktail solution was added, which 
consisted of RecA, poly(dT) ssDNA, MgOAc2, and Tris-glycerol buffer (pH of 
7.5) with final concentrations in each well corresponding to 0.5 µM RecA, 5 uM 
nts poly(dT), 10 mM MgOAc2, 25 mM Tris·HOAc and 5 % v/v glycerol. Column 
1, designated as the negative control column, contained 85 µL of an identical 
solution of this cocktail without the addition of poly(dT) and was added with a 
multichannel pipetter. 
Once all of the reagents were added to the plate, the plate was shaken at 
800 rmp for 30 sec and then placed in a 37°C incubator for 20 min. To each well 
of the assay plates, 10 µL of 7.5 mM stock of ATP (prepared in H2O) was added 
to give a final concentration of 0.375 mM of ATP. The plate was shaken t 800 
rpm for 30 sec and incubated at 37°C for 35 min, thus allowing the ATPase 
reaction to proceed. After this incubation time, 100 µL of the 1X PMB dye was 
added to all of the wells with a multichannel pipetter and the platew s shaken at 
600 rpm and incubated at room temperature for 5 min. Using a POLARstar 
OPTIMA plate reader (BMG Labtech, Durham, NC), the plates were scanned for 
absorbance at 650 nm. Subsequent screening data informatics were processed 
using KaleidaGraph (Synergy Software, Reading, PA) and Microsoft Excel 2003 
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(Microsoft, Redmond, WA). For analysis, the percent inhibition of RecA ATPase 
activity was determined. This was done on a plate-to-plate basis, wh ch compared 

















 ×100  
 
where A650 was the absorbance value at 650 nm in the presence of an inhibitor, 
µmin was the value of the plate average minimum A650
 signal control (i.e. average 
negative control) and µmax was the value of the plate average maximum A650
 signal 








THE DEVELOPMENT OF CHLORAMPHENICOL RESISTANT MAY BE 




Chloramphenicol is a broad-range bacteriostatic chemical agent used in 
the laboratory and in clinical practice to treat various gram-positive and gram-
negative bacterial infections. It is able slow bacterial growth by inhibiting 
peptidyl transferase by binding to the 50S ribosomal RNA and therefore prevents 
peptide bond formation, which in return slows protein synthesis[11]. This drug was 
introduced in the late 1940’s and resistance to this drug was first reported a mere 
ten years later[5]. Cells develop resistance to chloramphenicol in various ways, 
including an active efflux pump, reduced membrane permeability, alteration of 
the 50S ribosome through mutations in the 23S rRNA (G2057A), and full-fledged 
resistance that allows the cell to synthesize chloramphenicol acetyl transferase 
that renders the chloramphenicol ineffective by altering its structure to 1,3-
diacetoxychloramphenicol, which is unable to bind the hydrophobic pocket of the 
50S ribosome[7,9-18].  
RecA may or may not be involved in the resistance development of 
bacterial cells to chloramphenicol. This is due to the fact that chloramphenicol is 
bacteriostatic as opposed to bactericidal[36]. With bactericidal agents, DNA 
damage is typical, which would inevitably lead to DNA repair and possibly the 
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induction of the SOS response[26,27,36]. RecA would of course be activated in this 
process. But with bacteriostatic agents that are not present in excessive 
concentrations (which would act as a bactericidal agent), SOS is not induced[36]. 
Therefore, the question arises if RecA would be turned on or not. And if 
chloramphenicol works by inhibiting protein synthesis, would RecA necessarily 
be synthesized in excess? Theoretically, if RecA is involved and is synthesized, 
then an inhibitor compound designed to hinder RecA’s ability within the cell 
would impede or delay the resistance development of cells to chloramphenicol. If 
RecA is not involved or is not able to be synthesizd, then resistance development 
to chloramphenicol would proceed as expected. Also, if RecA is knocked out, 
then an inhibitor compound designed to inhibit RecA would have no effect on the 
resistance development assuming RecA is involved in the resistance development 
process; therefore cells grown in its presence or not would be expected to not 
grow or develop resistance. However, if RecA is not implicated in this process, 
then resistance would develop normally, whether the RecA inhibitor compound is 
present or not.  
Small molecules are attractive candidates for inhibitor compounds against 
the RecA protein, due to their ability to easily penetrate the cell. One such 
compound was discovered by Dr. Tim Wigle of the Singleton laboratory, in 
collaboration with Director Li-An Yeh and Professor Jonathon Sexton, while 
screening a chemical library of 35,780 small molecul s for RecA inhibitors at the 
Biomanufacturing and Research Institute and Technology Enterprise located at 
North Carolina Central University (work to be published in the Journal of 
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Biomolecular Screening). From this screen came seventy-three hit compounds, 
which yielded five promising chemotype clades. One of these chemotype clades, 
designated A1, proved to be the most promising candid te with an IC50 value of 8 
± 1 µM while tested in vitro with RecA. It also demonstrated inhibition of strand 
exchange and SOS induction in other studies (work dne by Dr. Tim Wigle). 
Bacterial culture studies would confirm the ability of A1 to hinder resistance 
development if cells, assuming RecA is involved in the process.  
 
Bacterial Culture Studies of the Effects of Chloramphenicol  
on Wild Type E. coli MG1655 cells 
 
 
Reported resistance to chloramphenicol in hospitals usually refers to the 
production of chloramphenicol acetyl transferase, which is utilized by cells to 
alter chloramphenicol in the cell, rendering it ineffective. This reaction occurs in 
two steps:  (1) chloramphenicol is converted to 3-acetoxychloramphenicol by 
chloramphenicol acetyl transferase acetylating the hydroxyl group on the third 
position on the side chain of chloramphenicol; (2) 3-acetoxychloramphenicol is 
converted to 1,3-diacetoxychloramphenicol by a molecular rearrangement of the 
acetyl group from the third position to the first hydroxyl position, then 
chloramphenicol acetyl transferase acetylates the hydroxyl group on the third 
position again on the side chain of chloramphenicol.  The acetyl groups are 
donated from acetyl coenzyme A, which is converted o coenzyme A as a 
byproduct.  
However, in laboratory experiments, this type of resistance is most likely 
not observed because this is an advanced stage of resistance. In bacterial culture 
 51
experiments observing the first 100 hours of cell growth, one is more likely to 
observe initial stages of resistance, including a combination of active efflux 
pumps and reduced membrane permeability. There is a possibility that RecA 
would not be involved in the process of low level rsistance to chloramphenicol, 
since DNA damage is not occurring and protein synthesis is slowed or attenuated 
(meaning the production of excess RecA would be attenuated).  
To observe how chloramphenicol would affect wild type MG1655 cells in 
the initial stages of resistance development, a one-flask resistance assay was 
utilized.  Briefly, this assay observed the growth of 50 mL cultures of MG1655 
wt. cells in the presence of 0, 5 and 10 µg/mL of chloramphenicol for 100 hours 
by periodically monitoring the optical density of the cultures at a wavelength of 
600 nm. When no chloramphenicol was added, cultures grew normally to 
saturation, or OD600 of 2, within 10 hours (Figure 3.1A, bottom panel, gray dotted 
line with open triangles) and had an MIC of about 8 µg/mL of chloramphenicol. 
When 10 µg/mL of chloramphenicol was added, cultures were unable to grow 
past an OD600 of 0.4 (Figure 3.1A, bottom panel, gray dotted line with open 
inverted triangles), thus indicating that cells were unable to develop resistance to 
chloramphenicol at this concentration. Lastly, resistance to chloramphenicol was 
observed in cultures grown in the presence of 5µg/mL at about 40-60 hours, as 
shown by the increase of OD600 over time (Figure 3.1A, bottom panel, gray dotted 
line with closed circles) and the increase of the mini um inhibitory concentration 
(MIC) from approximately 8 µg/mL of chloramphenicol to 32-48 µg/mL (Figure 
3.1A, top panel, gray dotted line with solid circles), as determined by E-tests. 
 52
However, whether or not RecA is involved in the resistance process is not clear 
from this data. 
These results were shown to be reproducible (Figures 3.1B-D). The MICs 
for all experiments begin around 6-12 µg/mL and reach an MIC of 24-96 µg/mL. 
However, for the culture with 5 µg/mL of chloramphenicol in the third 
experiment (Figure 3.1C), possible resistance development to chloramphenicol 
was not observed until over 100 hrs when the OD600 approached 0.5, but did not 
reach 0.6 or above. Because the culture did not grow above OD600 of 0.6, the MIC 

















Figure 3.1 Resistance Development of MG1655 wild type cells in the presence of Cam 
and A1. 
A-D show four separate experiments. Bottom panels show the OD600 vs time: gray dotted 
line with open triangles, 0 µg/mL Cam only; gray dotted line with closed circles, 5 µg/mL 
Cam only; gray dotted line with open inverted triangles, 10 µg/mL Cam only; red dotted 
line with open triangles, 0 µg/mL Cam and 50 µM A1; red dotted line with closed circles, 
5 µg/mL Cam and 50 µM A1; red dotted line with open inverted triangles, 10 µg/mL Cam 
and 50 µM A1. Top panel shows the MIC vs time: dotted gray line with closed circles, 5 
µg/mL Cam only. 
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Bacterial Culture Studies of the Effects of Chloramphenicol  
on ∆recA E. coli MG1655 cells 
 
 
As stated in the previous section, low level resistance development to 
chloramphenicol would include reduced membrane permeability and an active 
efflux pump to hinder chloramphenicol from entering the cell and if it gets in the 
cell, then the efflux pump would eject it promptly from the cell. However, this 
kind of resistance development would most likely be RecA independent due to 
lack of DNA damage and SOS induction. Therefore, a cell line that is incapable of 
expressing recA would be able to demonstrate the involvement or lack of 
involvement of RecA If RecA is implicated in the resistance development of 
MG1655 E. coli cells, than resistance to chloramphenicol in a cell culture with a 
cell line deficient in recA would not develop resistance over time However, if the 
pathway of chloramphenicol resistance development is RecA independent, than 
resistant development in cultures of MG1655 ∆recA E. coli cells would ensue as 
observed in the previous  section with wild type cells.  
To observe how chloramphenicol would affect MG1655 ∆recA cells in the 
initial stages of resistance development, a one-flask resistance assay was again 
utilized.  Briefly, this assay observed the growth of 50 mL cultures of MG1655 
∆recA cells in the presence of 0, 5 and 10 µg/mL of chloramphenicol for 100 
hours by periodically monitoring the optical density of the cultures at a 
wavelength of 600 nm. Upon observation of the MG1655 ∆recA culture over 
approximately 100 hours of incubation in the absence of chloramphenicol, cells 
grew to saturation between 10-15 hrs (Figure 3.2A, bottom panel, blue dotted line, 
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open triangles). Using an E-test to determine the MIC of this culture, cells were 
shown to have an MIC of about 8 µg/mL of chloramphenicol. When in the 
presence of 10 µg/mL, cells did not grow above an optical density of 0.3 as seen 
in Figure 3.2A with the blue dotted line and open inverted triangles in the bottom 
panel. Interestingly, a culture grown in the presence of 5 µg/mL did grow after 45 
hours, reaching an OD600 of 0.6 between 55-60 hours (Figure 3.2A, bottom panel, 
blue dotted line with closed squares). The E-test confirmed resistance 
development to chloramphenicol, reaching an MIC of about 48 µg/mL.  
After reproducing this assay (Figures 3.2B-C), it is apparent that the MICs 
for all experiments were between 6-8 µg/mL of chloramphenicol when no 
chloramphenicol was added to the cultures and between 24-48 µg/mL in the 
presence of 5 µg/mL of chloramphenicol in the cultures. Times when growth was 
observed was also consistent between experiments, 10-15 hours without 
chloramphenicol and 40-50 hours when 5 µg/mL was present. These results 
suggest RecA is not involved in the resistance development to chloramphenicol, 
due to the fact that the results of this assay involving ∆recA cells are consistent 
with the results with wild type cells. Regardless of whether RecA is present or not 
seems to have no bearing on the development of resistance to chloramphenicol 
when 5 µg/mL is added to the cultures. This is most likely due to the nature of 
chloramphenicol resistance development, which does n t rely on RecA to induce 
the SOS response. Rather, the process involves the expr ssion of efflux pumps 
and reduced expression of membrane porins. Therefor, cells devoid of RecA 













Figure 3.2 Resistance Development of MG1655 wild type cells in the presence of Cam 
and A1. 
A-C show three separate experiments. Bottom panels show the OD600 vs time: blue dotted 
line with open triangles, 0 µg/mL Cam only; blue dotted line with closed squares, 5 
µg/mL Cam only; blue dotted line with open inverted riangles, 10 µg/mL Cam only; red 
dotted line with open triangles, 0 µg/mL Cam and 50 µM A1; red dotted line with closed 
circles, 5 µg/mL Cam and 50 µM A1; red dotted line with open inverted triangles, 10 
µg/mL Cam and 50 µM A1. Top panel shows the MIC vs time: dotted blue ine with 
closed squares, 5 µg/mL Cam only. 
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Bacterial Culture Studies of the Effects of A1  
on Wild Type E. coli MG1655 cells 
 
 
One of the main goals of this laboratory is to find compounds that inhibit 
the RecA protein in hopes that DNA repair mechanisms and SOS induction can 
be avoided in order to eliminate bacterial infections, either as a stand-alone agent 
or in conjunction with other current antibiotics, to prevent the spreading and 
incorporation of antibiotic resistant genes. During a HTS performed by Dr. Tim 
Wigle of the Singleton laboratory, 73 such potential compounds were discovered, 
including the compound A1. 
The compound designated A1 for investigational purposes was shown to 
have a low IC50 value when screened in vitro in RecA ATPase assays, thus 
indicating it may have inhibitory effects against RecA. It also demonstrated the 
ability to inhibit strand exchange between cssDNA and dsDNA in vitro and SOS 
induction within cells in conjunction with ciprofloxacin, a bactericidal agent (see 
Dr. Tim Wigle dissertation for results). Therefore, the question of whether or not 
this compound could demonstrate effectiveness in delaying or preventing the 
resistance development of bacterial cells to antibiotics arose. Chloramphenicol 
was chosen to start because RecA is typically not implicated in the resistance 
development of cells to chloramphenicol, seeing as chloramphenicol is a 
bacteriostatic agent and does not induce the SOS response. Therefore, adding an 
inhibitor of RecA should have no effect on the resistance development to 
chloramphenicol.  
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Again, utilizing the one-flask resistance assay, 50 µM of A1 was added to 
the cultures of MG1655 wild type E. coli cells with 0, 5 and 10 µg/mL of 
chloramphenicol. As expected, cells grown without chloramphenicol and in the 
presence of only 50 µM of A1 grew to saturation within ten hours, as would 
cultures without A1 (Figure 3.1A, bottom panel, red dotted line with open 
triangles). This is because A1 is not capable of killing cell cultures on its own; it 
is not a bactericidal agent. Cells grown in the presence of 50 µM of A1 and a 
lethal dosage of chloramphenicol, 10 µg/mL, are unable to grow above an OD600 
of 0.4 (Figure 3.1A, bottom panel, red dotted line with open interved triangles). 
This is an indication that the cells were not able to develop resistance to 
chloramphenicol. Lastly, when a sub-lethal dosage of 5 µg/mL of 
chloramphenicol was added to cultures in conjunctio with 50 µM of A1, cells 
did not grow above an OD600 of 0.4, as opposed to the observation as was seen in 
cultures when A1 was not present (Figure 3.1A, bottom panel, dotted red line with 
closed circles). Cells do not always reach saturation of OD600 = 2 or even reach an 
OD600 = 0.6, therefore MIC values were not determined. As seen in Figures 3.1B-
D, these results are reproducible.  These results indicate that A1 is able to deter 
the cell’s ability to develop resistance to chloramphenicol. However, if this truly 
is the case, then A1 is not necessarily an inhibitor of RecA as previously believed. 
If it is truly deterring the resistance development to chloramphenicol, then it is 
able to hinder resistance development through a mechanism possibly independent 




Bacterial Culture Studies of the Effects of A1  
on ∆recA E. coli MG1655 cells 
 
Technically speaking, if RecA is necessary for the d velopment of 
resistance of MG1655 E. coli cells to chloramphenicol, then having cells with 
RecA knocked out would not develop resistance in the presence of a sub-lethal 
dosage of antibiotic. However, as seen in Figures 3.2A-C, it was observed that 
resistance had indeed developed in cultures with the concentration of 
chloramphenicol of 5 µg/mL, thus indicating that RecA is not implicated in the 
development of resistance to chloramphenicol. Therefore, the addition of a RecA 
inhibitor should have no effect on the development of resistance if RecA is not 
implicated in the process because the process either does not require the presence 
of RecA and resistance will develop. If resistance is not observed, then the 
compound being added is not necessarily an inhibitor of RecA because it still is 
able to deter resistance development when RecA, its supposed target, is absent. 
Therefore, to really test the compound A1 as an inhib tor of RecA, it was used in 
the one-flask resistance assay. 
As expected, when no chloramphenicol is added to cultures, cells grow to 
saturation within 10-15 hours (Figure 3.2A, bottom panel, red dashed line with 
open triangels) and are not resistance to chloramphenicol, as indicated by the low 
MIC value of 6-8 µg/mL. A concentration of 10 µg/mL of chloramphenicol is 
capable of stopping cultures from growing above andOD600 of 0.3 and therefore 
not allowing for resistance development (figure 3.2A, red dashed lines with open 
inverted triangles). Surprisingly, the addition of A1 to the cultures at a 
concentration of 50 mM and in the presence of 5 µg/mL of chloramphenicol 
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attenuates resistance development of MG1655 ∆recA cells to chloramphenicol 
(Figure 3.2A, bottom panel, dashed red lines with closed squares). Therefore, A1 
is able to prevent resistance, but has no RecA effect. It is likely that RecA is not 
needed for resistance development to chloramphenicol and A1 may inhibit 
resistance through a RecA independent pathway.  
These same results were seen in concurring experiments (Figures 3.2B-C).  
All experiments showed cultures growing to saturation in 10-15 hours with MIC 
values in the 6-8 µg/mL range when no chloramphenicol was added and did not 
grow in the presence of 10 µg/mL of chloramphenicol. Cultures with 5 µg/mL of 
chloramphenicol added were also consistent in that ey all did not develop 




With antibiotic resistance development on the rise, finding novel means of 
combating bacteria to not only kill them, but to hinder their resistance developing 
mechanisms is in great demand. Making bacteria devoi  of a mode of resistance 
development would reduce the spread of resistant genes by abrogating 
horizontally transferred resistant genes and mutations arising from the SOS 
response. Since recombinase protein A is implicated in the spreading of resistance 
genes through horizontal gene transfer and homologous recombination or through 
induction of the SOS mutagenesis pathway, it is a very promising target. Thus, 
inhibiting RecA in the cells would aid in the reduction of resistance development 
to antibiotics. 
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In this study, when introducing the antibiotic chloramphenicol to cultures 
of MG1655 E. coli wild type and ∆recA cells, cultures with a sub-lethal dosage of 
chloramphenicol (5 µg/mL) did develop resistance over time to the antibiotic. 
This would indicate that low level resistance development to chloramphenicol 
involving active efflux pumps and reduced membrane permeability would not 
include the RecA protein, as demonstrated by the on-flask resistance assay 
utilized in this study. Taking this one step furthe, the resistance observed was 
most likely not due to homologous recombination of h rizontally transferred 
genes or SOS induction, since resistance was still observed in RecA knockout 
cells. Mutations necessary to slow or cease the production of porins on the cell 
surface (through which chloramphenicol would enter th  cell) and activate efflux 
pumps would have been created through a RecA indepent pathway.  
The results of this type of resistance assay are confounding for an 
understandingn of the small molecule A1. Through screening and various 
experiments performed by Dr. Tim Wigle of the Singleton laboratory, the results 
of those experiments demonstrated the ability of A1 to hinder strand exchange 
between single stranded DNA and double stranded DNA in a strand exchange 
assay, the turnover of ATP in an ATPase assay and the induction of SOS as 
observed in a GFP SOS induction assay. All of these processes are controlled by 
RecA, which gives strong evidence to believe that A1 is a RecA inhibitor. 
However, the results of this study show that resistance development to 
chloramphenicol is inhibited in the presence of this compound. A1 obviously does 
not need RecA to be present to hinder resistance dev lopment, thus further 
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demonstrating that RecA is not necessary for chloramphenicol resistance 
development in MG1655 E. coli cells or that A1 has another mechanism of action 
within cells. More studies need to be completed to understand how A1 functions 
in the cell.  
Lastly, the next step to understanding the involvement of RecA in 
bacterial culture studies would be to run the one-flask resistance assay with other 
antibiotics that are known to induce DNA damage, such as ciprofloxacin, and 
bactericidal agents such as ampicillin and kanamycin. Using these agents would 
induce DNA repair pathways by activating RecA and iactivating the repressor 
protein LexA, which allows for the expression of DNA repair proteins, including 
SOS mutagenic proteins. Knowing that RecA is needed for cell survival and 
resistance development to these antibiotics, this would serve to understand in 
more detail the ability of MG1655 E. coli cells to develop resistance to other 
antibiotics, as well as to clarify if A1 needs RecA to inhibit resistance 
development. Studies of the r cA knockout strain might prove to have different 
results when cultured with or without A1 if A1 truly is a RecA inhibitor, meaning 
∆recA cells with or without A1 should not develop resistance because resistant 
development is most likely dependent on RecA and the addition of an RecA 
inhibitor would make no difference (even if it does prevent resistance through a 
different pathway, there would still be no resistant development observed).  The 
results for the wild type strain should remain the same if A1 is able to inhibit 
RecA. However, if A1 inhibits resistance in a RecA independent manor, then 
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resistance to these antibiotics might still ensue, d pending on the means of 








APPLICATION OF THE GRIFFITH EXPERIMENT TO ESCHERICHIA COLI  
MG1655 CELLS TO OBSERVE THE POTENTIAL TRANSFER  




During World War I, many soldiers were dying of pneumonia infections. 
In an attempt to aid soldiers fighting in this war, F ederick Griffith studied strains 
of Streptococcus pneumoniae in mice in attempts to uncover a vaccine against 
pneumonia.  Using two strains of S. pneumoniae, an avirulent strain (R or rough 
strain) lacking a polysaccharide capsule and a virulent strain incorporating a 
polysaccharide capsule (S or smooth strain), he injected mice with these strains 
and observed if and when they died[37]. When injected with an R strain, the mice 
did not acquire pneumonia and lived. But mice injected with the S strain acquired 
pneumonia and died within a few days. The polysacchride capsule is essential 
for virulence of S. pneumoniae in that it protects the bacteria from attack inflicted 
by the human immune system. The question arose of whether the avirulent strain 
could become virulent if in the presence of dead virulent cells, which would 
enable the avirulent strain to incorporate a capsule to protect itself. Therefore, 
when mice were injected with a mixture of living R and heat-killed S strains, the 
mice developed pneumonia and died[37]. As a control, mice were injected with 
heat-killed S cells and did not acquire pneumonia, therefore enabling them to live. 
Upon isolation and analysis of the strains extracted from the mice, Griffith 
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observed that all of the S. pneumoniae contained a polysaccharide capsule[37]. 
Somehow, the heat-killed S strain transferred information to the avirulent R 
strain, which allocated the capability of the R strain to develop a protective 
capsule. Thus, the transforming principle was born.  
How this could happen remained elusive until the 1940’s when Avery and 
colleagues observed that the addition of ribonucleases, chymotrypsin and trypsin 
(used for the breakdown of proteins and peptides) had no effect on S. 
pneumoniae’s ability to transform the R strain to the S strain in the presence of 
the heat-killed S strain, thus disproving the common theory that proteins were 
responsible for this phenomenon[38]. But the addition deoxyribonucleopolymerase 
abrogated the transformation of the R strain to the S strain in the presence of the 
heat-killed S strain[38]. Finally, it was demonstrated that DNA was responsible for 
this transformation. The DNA from the heat-killed S strain was able to be taken 
up by the R strain and incorporated into its genome, th refore encoding the 
genetic information for the production of the polysaccharide capsule.  
RecA is believed to be a part of this pathway by aiding the incorporation 
of the genes through homologous recombination and possibly with transport 
inside the cell by coating ssDNA upon entry into the cell, thus protecting it from 
nucleases[4,19,26,27]. Therefore, by inhibiting RecA, the transfer and icorporation 
of genes through transformation can be prevented. This can be an effective means 
of preventing the spreading of antibiotic resistant genes.  
As mentioned, Streptococcus pneumoniae is able to uptake and 
incorporate DNA naturally, meaning it is naturally competent[4,40,41]. There are 
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other strains, both gram-positive and gram-negative, hat are naturally competent, 
such as Neisseria gonhorraea, Helicobacter pilori and Bacillus subtillis. 
However, Eschericia coli is not thought to be naturally competent, despite some 
evidence to the contrary[39-45]. If E. coli is to be defined as naturally competent, 
then the transformation efficiency is very low compared to other strains.  
MG1655 is a strain of E. coli that has very few genetic modifications, 
therefore it is a strain that is very similar to one that would be found in a 
patient[67]. Some of its genetic modifications include a knockout of the F factor, 
which disables the bacteria’s ability to transfer genes through conjugation by 
hindering its ability to assemble a sex pilus; a knockout of λ, which prevents the 
degradation of foreign DNA upon entry into the cell; and rfb-50, which is an IS5 
insertion sequence that results in the absence of O-antigen, thus resulting in a 
rough lipopolysaccharide (LPS) and increasing the permeability for hydrophobic 
antibiotics[67]. These genetic modifications are of interest when studying the 
possibility that E. coli could be naturally competent because conjugation can be 
ruled out as the means of gene transfer. Also, if genes are being taken up through 
naturally occurring mechanisms, then they will not be degraded upon entry into 
the cell. Also, having a rough LPS could also mean l ss barriers for DNA to battle 
when attempting to enter the cell due to less forces of repulsion between 
negatively charged LPS and negatively charged DNA.  
Taking all of this into account, if E. coli is able to take up DNA naturally 
like S. pneumoniae is able, whether by a similar or unique pathway, then 
resistance to antibiotics would develop more quickly in the presence of heat-killed 
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cells that are resistant to that antibiotic than cells that are not in the presence of 
heat-killed resistant cells due to the uptake and incorporation of the resistant 
genes present in the supernatant of the heat-killed cells. Also, assuming RecA is 
involved in this process of DNA uptake and/or incorporation, an inhibitor of 
RecA would be able to deter this process. Therefore, th  potential inhibitor 
compound A1 (discovered in a RecA ATPase HTS performed by Dr. Tim Wigle 
in collaboration with Dr. Jonathan Sexton and Director Li-ahn Yeh at the BRITE 
center at NCCU) is an ideal candidate to test this theory.  
 
 
Bacterial Culture Studies of the Effects of the Addition of Chloramphenicol  
Resistant Cell Supernatant on Wild Type E. coli MG1655 cells 
 
 
Back in 1929, Dr. Griffith observed a rather intriguing phenomenon. 
While experimenting on mice, he discovered the transfer of information between 
Streptococcus pneumoniae. While injecting mice with an avirulent, or rough, 
strain of Streptococcus pneumoniae, the mice did not develop pneumonia and 
lived. As expected, when injected with a living virulent, or smooth, strain, the 
mice did develop pneumonia and died. But when the mice were injected with a 
heat-killed virulent strain, the mice of course lived. However, when injected with 
a combination of the heat-killed virulent strain and the avirulent strain, the mice 
acquired pneumonia and died. Somehow, something from the heat-killed virulent 
strain was being transferred to the avirulent strain, informing it how to make itself 
virulent.  
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Scientists first predicted that proteins were respon ible for this 
phenomenon, that proteins were carrying the information from the heat-killed 
virulent strain to the avirulent strain. It was not until 1944 when Avery and 
colleagues determined that DNA was responsible for this transfer of information. 
What actually happened was the DNA responsible for encoding the 
polysaccharide capsule that protects the bacteria from the human immune system 
was leaked from the heat-killed cells. The avirulent strain was able to take up and 
incorporate these genes into its own genome, therefore expressing the virulent 
factor, a process that is most commonly referred to as transformation. 
Streptococcus pneumoniae is able to perform transformation naturally through 
signaling pathways and the utilization of various proteins, including the RecA 
protein, which aids in homologous recombination of the newly acquired genes 
and possible through uptake by protecting the DNA from nucleases upon entry 
into the cell. 
Since the transfer of antibiotic resistant genes through transformation is a 
major concern, being able to observe this in cultures is of interest. Applying the 
Griffith theory to E. coli, growing wild type cultures in the presence of heat-killed 
antibiotic resistant cell supernatant theoretically should develop resistance to that 
antibiotic faster than cells grown without the antibiotic resistant cell supernatant 
due to the uptake and incorporation of the resistant ge es from the heat-killed 
resistant cells. This theory was tested using the on -flask resistance assay with 
chloramphenicol.  
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Briefly, the one-flask resistance assay is conducted by observing the 
growth of 50 mL cultures of MG1655 wt. cells in the presence of 0, 5 and 10 
µg/mL of chloramphenicol and with or without 1 mL of heat-killed 
chloramphenicol resistant cell supernatant for 100 hours by periodically 
monitoring the optical density of the cultures at a w velength of 600 nm. To 
confirm resistance development, an E-test is performed. In cultures without 
chloramphenicol, cells with and without chloramphenicol resistant cell 
supernatant grow to saturation, or an OD600 of 2, within 10 hours (Figure 4.1A, 
bottom panel: Cam only, dotted gray line with open triangles; Camr and Cam, 
solid green line with open triangles). In the presence of 10 µg/mL of 
chloramphenicol, cells did not grow above OD600 of 0.4, whether in the presence 
of Camr supernatant or not (Figure 4.1A, bottom panel: Cam only, dotted gray 
line with open inverted triangles; Camr and Cam, solid green line with open 
inverted triangles). This result indicates that whether or not resistant genes were 
transferred from the resistant cells to the wild type cells, the dose of 
chloramphenicol was high enough to prevent the development of resistance. 
However, in the presence of a sub-lethal dosage of 5 µg/mL of chloramphenicol, 
cells in the presence of chloramphenicol resistant cell supernatant developed 
resistance to chloramphenicol faster than cells withou  chloramphenicol resistant 
cell supernatant as shown by the increase in OD600 over time; resistance 
development was observed between 24-40 hours with chloramphenicol resistant 
cells as opposed to 40-60 hours without the heat-killed chloramphenicol resistant 
cell supernatant (Figure 4.1A, bottom panel: Cam only, dotted gray line with 
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closed circles; Camr and Cam, solid green line with closed circles).  Also, under 
both conditions, the MIC increases from 6-12 µg/mL chloramphenicol to 24-96 
µg/mL, thus confirming the development of resistance (Figure 4.1A, top panel: 
Cam only, dotted gray line with closed circles; Camr nd Cam, solid green line 
with closed circles). 
These results were shown to be reproducible (Figures 4.1B-D). The MICs 
for all experiments with or without heat-killed chloramphenicol resistant cell 
supernatant begin around 6-12 µg/mL and reach an MIC of 24-96 µg/mL. 
However, for the culture with 5 µg/mL of chloramphenicol in the third 
experiment (Figure 4.1C), possible resistance development to chloramphenicol 
was not observed until over 100 hrs when the OD600 approached 0.5, but did not 
reach 0.6 or above. Because the culture did not grow above OD600 of 0.6, the MIC 
was not determined. The culture with 5 µg/mL of chloramphenicol and heat-killed 
chloramphenicol resistant cell supernatant did develop resistance faster than 
chloramphenicol only, but did so more slowly than in the other experiments 
(Figures 4.1A, B and D). These results do indicate that chloramphenicol resistant 
genes from the heat-killed cells are being transferred to the wild type cells and are 





Figure 4.1 Resistance Development of MG1655 wild type cells in the presence of Cam and heat-killed 
Camr cells. 
A-D are four experimental results for this assay. Bottom panels show the OD600 vs time: gray dotted line 
with open triangles, 0 µg/mL Cam only; gray dotted line with closed circles, 5 µg/mL Cam only; gray dotted 
line with open inverted triangles, 10 µg/mL Cam only; green solid line with open triangles, 0 µg/mL Cam 
and heat-killed Camr cells; green solid line with closed circles, 5 µg/mL Cam and heat-killed Camr cells; 
green solid line with open inverted triangles, 10 µg/mL Cam and heat-killed Camr cells. Top panels show the 
MIC vs time: dotted gray line with closed circles, 5 µg/mL Cam only; solid green line with closed circles, 5 
µg/mL Cam and heat-killed Camr cells. 
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Bacterial Culture Studies of the Effects of the Addition of Chloramphenicol  
Resistant Cell Supernatant on ∆recA E. coli MG1655 cells 
 
 
While attempting to apply the Griffith experiment to E. coli MG1655 
cells, one would expect the wild type cells to have  means of incorporating the 
antibiotic resistant genes from the heat-killed resistant cells into the genome to 
enable the wild type cells to become resistant to the antibiotic, chloramphenicol in 
this particular study.  RecA is suspected to be implicated in this process by 
utilizing homologous recombination of the DNA from the resistant cells and by 
possibly protecting the DNA from nucleases upon entry into the cell. In the 
previous chapter, it was demonstrated that RecA is not needed for the 
development of resistance to chloramphenicol, but the previous section of this 
chapter suggests that RecA can accelerate the developm nt of resistance by 
exploiting eDNA from resistant cells. Therefore, performing the same 
experiments with a strain lacking RecA is essential to further elucidating this 
theory of the usage of resistance genes from external DNA.  
Theoretically, if the cells are incorporating the resistant genes by uptaking 
external DNA from the media and making use of homolog us recombination 
through a RecA dependent pathway, then removing RecA from the cells would 
attenuate this process. However, if resistance to chl ramphenicol is a RecA 
independent process, as demonstrated in the previous chapter, then resistance can 
still develop, but will do so at about the same speed as cells without heat-killed 
chloramphenicol resistant cells present.  
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Upon analysis of MG1655 ∆recA cells in the one-flask resistance assay, it 
is apparent that in the presence of heat-killed chloramphenicol resistant cells, cells 
grown without any chloramphenicol grow to saturation in about 10-15 hours 
(Figure 4.2A, bottom panel, solid green line with open triangles). Upon the 
addition of 10 µg/mL of chloramphenicol and heat-killed chloramphenicol 
resistant cells, the recA knockout cells do not grow and are therefore assumed to 
have not developed resistance (Figure 4.2A, bottom panel, solid green line with 
open inverted triangles). The cultures grown in these conditions behave as 
expected. But when 5 µg/mL of chloramphenicol and heat-killed chloramphenicol 
resistant cells were present, the results that ensued are two fold: since the cells 
began to grow around 40 hours (Figure 4.2A, bottom panel, solid green line with 
closed circles) and had an MIC reaching 64 µg/mL (Figure 4.2A, top panel, solid 
green line with closed circles), the obvious conclusions are that RecA is needed to 
incorporate the resistant genes in order to accelerat  the resistance development 
and the cells are still able to develop resistance to chloramphenicol at the same 
rate as the culture without heat-killed chloramphenicol resistant cells, therefore 
indicating a RecA independent pathway of resistance development as shown in 
the previous chapter.  
Repeats of this experiment further supported the conclusions made in this 
experiment (Figures 4.2B-C) by confirming quick growth of cultures without 
chloramphenicol, no growth with 10 µg/mL and growth of cultures with 5 µg/mL 
and heat-killed chloramphenicol resistant cells betwe n 40-50 hours with MICs 
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increasing to 32-64 µg/mL, which correlated with the cultures without heat-killed 





Figure 4.2 Resistance Development of MG1655 ∆recA cells in the presence of Cam and heat-killed 
Camr cells. 
A-C show three experimental results for this assay. Bottom panels show the OD600 vs time: blue dotted line 
with open triangles, 0 µg/mL Cam only; blue dotted line with closed squares, 5 µg/mL Cam only; blue 
dotted line with open inverted triangles, 10 µg/mL Cam only; green solid line with open triangles, 0 µg/mL 
Cam and heat-killed Camr cells; green solid line with closed squares, 5 µg/mL Cam and heat-killed Camr 
cells; green solid line withopen inverted triangles, 10 µg/mL Cam and heat-killed Camr cells. Top panels 
show the MIC vs time: dotted blue line with closed squares, 5 µg/mL Cam only; solid green line with closed 
squares, 5 µg/mL Cam and heat-killed Camr cells. 
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Bacterial Culture Studies of the Effects of the Addition of A1 and 




Bacteria have almost an unfathomable capability to survive compared to 
many organisms in existence. Especially when placed under stressful conditions, 
they have adopted various means of bypassing the stress in order to survive. 
Antibiotics, once thought to be a miracle when first ntroduced because of the 
many lives they saved by treating bacterial illnesses that were once life-
threatening, hardly pose a threat to bacterial infections in recent years due to the 
transfer of antibiotic resistant genes, whether through vertical or horizontal gene 
transfer. Therefore, instead of attempting to develop new antibiotics, perhaps a 
more cunning approach to outsmart bacteria is to impa r their resistance 
mechanisms, such as recombination, DNA repair mechanisms and SOS 
mutagenesis. RecA is an ideal target for this, since it is involved in all of these 
processes. RecA is also an ideal target to prevent the horizontal transfer of 
antibiotic resistance genes, since it aids in incorporation of the resistance genes 
into the genome of the recipient bacteria through homologous recombination and 
possibly aids in the uptake of exogenous DNA into the cell by coating it to protect 
it from nucleases.  
Compound A1 has proven to be a highly potential inhibitor of RecA by 
attenuating the resistance development of MG1655 wt. E. coli cells to 
chloramphenicol (see chapter II, section Bacterial Culture Studies of the Effects 
of A1 on Wild Type E. coli MG1655 cells). MG1655 wt. E. coli cells were also 
shown to develop resistance to chloramphenicol more quickly in the presence of 
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heat-killed chloramphenicol resistant cell supernata t, thus indicating that genes 
are being horizontally transferred from the dead cells to the live wt. cells (see 
Chapter IV, section Bacterial Culture Studies of the Effects of the Addition of 
Chloramphenicol Resistant Cell Supernatant on Wild Type E. coli MG1655 cells). 
Since RecA would be responsible for incorporating those genes into the genome 
of the wt. cells, inhibiting RecA would more or less attenuate the process of 
transferring the chloramphenicol resistant genes. Therefore, investigating if A1 
could also deter the resistance development of MG1655 wt. E. coli cells in the 
presence of heat-killed chloramphenicol resistant cell supernatant was worth 
observing.  
Using the one-flask resistance assay, the growth of 50 mL cultures of 
MG1655 wt. cells in the presence of 0, 5 and 10 µg/mL of chloramphenicol and 
50 µM of A1 with or without 1 mL of heat-killed chloramphenicol resistant cell 
supernatant was monitored for 100 hours periodically by recording the optical 
density of the cultures at a wavelength of 600 nm. To confirm resistance 
development, an E-test was performed. Within ten hours, cells grown without 
chloramphenicol grew to saturation, or an OD600 of 2 (Figure 4.3A, bottom panel, 
all lines with open triangles). There was no differentiation between cultures with 
or without heat-killed chloramphenicol resistant cells or A1. After 100 hours, it 
was apparent that cultures grown in the presence of 10 µg/mL of chloramphenicol 
did not grow above OD600 of 0.4. Again, there was no differentiation between 
cultures with or without heat-killed chloramphenicol resistant cells or A1 (Figure 
4.3A, bottom panel, all lines with open inverted triangles). As demonstrated 
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previously, the addition of heat-killed chloramphenicol resistant cells accelerated 
the resistance development to 5 µg/mL of chloramphenicol of MG1655 wt. cells 
(Figure 4.3A, bottom panel, solid green line with closed circles). But with the 
addition of 50 µM of A1, resistance development to chloramphenicol was not 
observed in the presence of 5 µg/mL of chloramphenicol, whether heat-killed 
chloramphenicol resistant cells were added or not (Figure 4.3A, bottom panel, 
dotted red lines with closed circles contains no resistant cells and magenta lines 
with closed circles contains resistant cells). See Figure 4.3B-D for reproducibility 
of this assay. Assuming A1 is truly an inhibitor of RecA, then the results of this 
assay show that A1 is able to hinder RecA’s ability to aid in the incorporation of 
chloramphenicol resistant genes into the MG155 wt. cells. If it is not a RecA 





Figure 4.3 Resistance Development of MG1655 wild type cells in the presence of Cam, heat-killed 
Camr cells and A1. 
A-D show four experimental results for this assay. Bottom panels show the OD600 vs time: gray dotted line 
with open triangles, 0 µg/mL Cam only; gray dotted line with closed circles, 5 µg/mL Cam only; gray dotted 
line with open inverted triangles, 10 µg/mL Cam only; red dotted line with open triangles, 0 µg/mL Cam and 
50 µM A1; red dotted line with closed circles, 5 µg/mL Cam and 50 µM A1; red dotted line with open 
inverted triangles, 10 µg/mL Cam and 50 µM A1; green solid line with open triangles, 0 µg/mL Cam and 
heat-killed Camr cells; green solid line with closed circles, 5 µg/mL Cam and heat-killed Camr cells; green 
solid line with open inverted triangles, 10 µg/mL Cam and heat-killed Camr cells; magenta solid line with 
open triangles, 0 µg/mL Cam, heat-killed Camr cells and 50 µM A1; magenta solid line with closed circles, 5 
µg/mL Cam, heat-killed Camr cells and 50 µM A1; magenta solid line with open inverted triangles, 10 
µg/mL Cam, heat-killed Camr cells and 50 µM A1. Top panels show the MIC vs time: dotted gray line with 
closed circles, 5 µg/mL Cam only; solid green line with closed circles, 5 µg/mL Cam and heat-killed Camr 
cells. 
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Bacterial Culture Studies of the Effects of the Addition of A1 and 
Chloramphenicol Resistant Cell Supernatant on ∆recA E. coli MG1655 cells 
 
 
In MG1655 wild type cells, experiments in this study thus far have shown 
that cultures in the presence of a sub-lethal dosage of chloramphenicol, cells are 
able to develop resistance to chloramphenicol most likely in a RecA independent 
manner. This was further supported when the assay results with ∆recA cells were 
still able to develop resistance to chloramphenicol at 5 µg/mL. However, when 
introduced to heat-killed chloramphenicol resistant cells, wild type cells were able 
to develop resistance more quickly than cells withou  the heat-killed cells while 
recA knockouts were not, which indicates that the uptake nd incorporation of the 
exogenous DNA through homologous recombination through a RecA dependent 
pathway is operational. But interestingly, A1, a compound thought to be an 
inhibitor of RecA, was shown to prevent resistance d velopment to 
chloramphenicol in all of these conditions thus far tested. This is perplexing, since 
this would indicate that A1 is not an inhibitor of RecA because the presence of 
RecA is not necessary for prevention of resistance development. Therefore, the 
last piece of the puzzle is necessary to elucidate: can A1 prevent the resistance 
development of MG1655 ∆recA cells to chloramphenicol when heat-killed 
chloramphenicol resistant cells are present.  
After conducting the one-flask resistance assay with the conditions of 0, 5 
and 10 µg/mL of chloramphenicol and heat-killed chloramphenicol resistant cells, 
the answer becomes clear: the answer is yes, A1 does appear to prevent the 
development of resistance to chloramphenicol in cultures grown with heat-killed 
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chloramphenicol resistant cells and 5 µg/mL of chloramphenicol as indicated by 
the lack of increase in OD600 (Figure 4.4A, bottom panel, solid magenta line with 
closed squares). The results of the control with no chloramphenicol were as 
expected: quick growth to saturation within 10-15 hours and therefore no 
resistance to chloramphenicol (MIC of about 8 µg/mL) (Figure 4.4A, bottom 
panel, solid magenta line with open triangles).  Also as expected, the culture with 
10 µg/ml of chloramphenicol and heat-killed chloramphenicol resistant cells does 
not grow (Figure 4.4A, bottom panel, solid magenta line with open inverted 
triangles). These results are twofold in that they indicate (1) A1 can hinder 
resistance development to chlorapmphenicol in a RecA independent manor, as 
already suspected from other results in this study; and (2) RecA would still be 
needed to incorporate the DNA encoding the resistant ge es present in the media, 
since resistance development still did not ensue whn t e heat-killed resistant 
cells were present.  
Replication of this assay yielded the same results (Figures 4.4B-C): (1) the 
quick growth of cultures with no chloramphenicol, 50 µM of A1 and heat-killed 
chloramphenicol resistant cells; (2) no growth of cultures with 10 µg/mL of 
chloramphenicol, 50 µM of A1 and heat-killed chloramphenicol resistant cells; 
and (3) cultures with 5 µg/mL of chloramphenicol, 50 µM of A1 and heat-killed 
chloramphenicol resistant cells did not develop resistance to chloramphenicol as 






Figure 4.4 Resistance Development of MG1655 ∆recA cells in the presence of Cam, heat-killed Camr 
cells and A1. 
A-C show three experimental results for this assay. Bottom panels show the OD600 vs time: blue dotted line 
with open triangles, 0 µg/mL Cam only; blue dotted line with closed squares, 5 µg/mL Cam only; blue 
dotted line with open inverted triangles, 10 µg/mL Cam only; red dotted line with open triangles, 0 µg/mL 
Cam and 50 µM A1; red dotted line with closed squares, 5 µg/mL Cam and 50 µM A1; red dotted line with 
open inverted triangles, 10 µg/mL Cam and 50 µM A1; green solid line with open triangles, 0 µg/mL Cam 
and heat-killed Camr cells; green solid line with closed squares, 5 µg/mL Cam and heat-killed Camr cells; 
green solid line with open inverted triangles, 10 µg/mL Cam and heat-killed Camr cells; magenta solid line 
with open triangles, 0 µg/mL Cam, heat-killed Camr cells and 50 µM A1; magenta solid line with closed 
squares, 5 µg/mL Cam, heat-killed Camr cells and 50 µM A1; magenta solid line with open inverted 
triangles, 10 µg/mL Cam, heat-killed Camr cells and 50 µM A1. Top panels show the MIC vs time: dotted 
blue line with closed squares, 5 µg/mL Cam only; solid green line with closed squares, 5 µg/mL Cam and 





Griffith and Avery in their time had some rather interesting discoveries: 
that bacteria cells could transfer information to one another via DNA. In S. 
pneumoniae, the virulence factor of a polysaccharide capsule was transferred 
from heat-killed virulent cells to avirulent cells, which were then able to 
incorporate these genes and protect themselves from the host’s immune response.  
This study used this concept to attempt to answer the question of whether 
antibiotic resistant genes could be transferred in E. coli cells in the same manor: 
could heat-killed chloramphenicol resistant cells excr te the DNA encoding for 
chloramphenicol resistance, which could be utilized by non-resistant cultures to 
develop resistance? When wild type MG1655 E. coli cells were introduced to 
heat-killed chloramphenicol resistant cells, resistance development was seen only 
at a concentration of chloramphenicol of 5 µg/mL, as seen by the increased 
optical density at 600 nm over time and the increased MIC from 6-12 µg/mL 
chloramphenicol to 24-96 µg/mL. The rate was also faster than wild type cells 
without the introduction of heat-killed chloramphenicol resistant cells by about 
10-20 hours. These results supported theory that chloramphenicol resistant genes 
could be transferred from heat-killed cells to non-resistant cells, but ∆recA cells 
would give a clearer picture, since it is needed for the incorporation of genes from 
exogenous DNA into the genome of the recipient cells. Upon their analysis, it was 
demonstrated that only cultures with 5 µg/mL of chloramphenicol were able to 
develop resistance. However, there was no differentiation between cultures with 
or without heat-killed chloramphenicol resistant cells added. Having compiled 
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results from both strains, the conclusions are thatexogenous DNA encoding 
chloramphenicol resistance can be uptaken and incorporated by MG1655 E. coli 
cells, but RecA is required for this process and resistance to chloramphenicol can 
ensue in a RecA independent manor, since ∆recA cells were still able to develop 
resistance to chloramphenicol.  
Various in vitro studies with A1 strongly indicated that it is an inhibitor of 
RecA (see the dissertation of Dr. Tim Wigle). Therefo , testing this compound in 
bacterial cultures in the one-flask resistance assay eemed to be a reasonable next 
step to ensure this compound was able to function in live cell cultures. In the 
previous chapter of this study, it was demonstrated that A1 was able to attenuate 
resistance development of MG1655 wild type and ∆recA E. coli cells to 
chloramphenicol. If only wild type cells did not develop resistance, then one 
could conclude that RecA is necessary for the resistance development to 
chloramphenicol and A1 is definitely an inhibitor of RecA. Since this is not the 
case, resistance to chloramphenicol seems to be RecA independent and A1 has no 
preference for RecA when inhibiting resistance development. This is further 
supported when heat-killed chloramphenicol resistant cells were added to 
cultures. Even though wild type cells developed resistance faster with the heat-
killed resistant cells and the ∆recA cells did not, again, A1 was still able to 
attenuate this process, thus confirming that it is able to deter resistance 
development in a RecA independent manor. Interestingly, even though wild type 
cells possessed the ability to incorporate the resistant genes from the heat-killed 
cells, because A1was present and did not require the inhibition of RecA to hinder 
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resistance, the incorporation of these genes was inconsequential when A1 was 
added to the cultures.  
Understanding the effects of adding heat-killed resistant cells and A1 
would be better understood when performing this study with other antibiotics that 
are bactericidal in nature, such as ciprofloxacin, kanomycin and ampicillin, which 
would more likely induce the SOS response in cells, thus depending on the 
involvement of RecA. If A1 attenuates resistance development in a RecA 
independent manor, then the results of studying these other antibiotics might show 
resistance development when A1 is present or might not, depending on the 
mechanism of action of each antibiotic. But the picture would be much clearer 
upon compilation of this data. However, the results of the addition of heat-killed 
resistant bacteria to wild type cells would most likely remain unchanged, since the 
incorporation of resistant genes accelerates the resistance development process. 
The addition to ∆recA cells could theoretically change, since RecA would most 
likely be necessary for the development of resistance with bactericidal agents, and 










UTILIZATION OF MOLECULAR MODELING METHODS OF SCREENING TO  





As the battle against the ever-evolving bacteria rages on, more and more 
antibiotic resistant bacteria emerge and therefore cu rent antibiotics are rendered 
ineffective against them. A high demand has been establi hed to discover 
chemical agents that can decimate these superbugs. Recent evidence has 
supported RecA as a novel target for battling these antibiotic resistant bacteria due 
to its involvement in SOS mutagenesis, DNA repair and recombinational-
dependent horizontal gene transfer[19-26],, which have been implicated in many 
bacteria’s ability to develop tolerance to treatment with chemical agents and 
inevitably will lead to fully developed resistance[26,27].  Hindering RecA’s ability 
to function displays tremendous potential to battle th se superbugs by sensitizing 
them to current antibiotics and prohibiting them to recover from antibiotic attack 
by inhibiting the resistance pathways. 
Small molecules that have the ability to penetrated the cell and inhibit 
RecA function are attractive candidates for drugable compounds. Theoretically, if 
these small molecules interact with the RecA protein and inhibit its function, 
synergistic effects can be observed with the use of current antibiotics, enabling 
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them to be more potent against bacteria and would decrease the spreading of 
bacterial strains already resistant to the current antibiotics.  
Dr. Tim Wigle of the Singleton laboratory, in collaboration with Director 
Li-An Yeh and Professor Jonathon Sexton, has had the opportunity to screen for 
such small molecules at the Biomanufacturing and Research Institute and 
Technology Enterprise (BRITE) located at North Carolina Central University 
(NCCU). He was able to screen a small chemical library of 35,780 small 
molecules against the RecA protein. From this screen came seventy-three hit 
compounds that were utilized in a molecular modeling project in collaboration 
with Dr. M. Karthikeyan in the Dr. Alexander Trohsha laboratory.  
In regards to drug discover, molecular modeling, the technique of 
mimicking the behavior of molecules, can be implemented by exploring structural 
and activity space in attempts to uncover molecules that have the desirable effects 
(in our case, inhibitors of the RecA protein) without having to spend many hours 
and much money screening libraries[68,69]. The hits from an already screened small 
molecule library at the BRITE center provided a basis to perform cost-effective 
and low budget screening. Implementing the molecular operating environment 
(MOE) program, similarity searching can be performed, which would uncover 
molecules with similar structures in the literature and that could potentially be 
commercially available. These molecules would theoretically have similar 
activities under the assumption that there is a strong correlation between structure 
and activity[68,69]. Compounds extracted from this search that already h ve a high 
potential of being active due to their structurally similarities to previously 
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established hit compounds can be tested in the laboratory to confirm or invalidate 
them as hit compounds against the RecA protein. Such compounds were extracted 
and explored as potential inhibitors of RecA. 
 
Various Prediction Methods and the Theory  
Behind Similarity Searching   
 
The theoretical basis for molecular modeling screening, in regards to 
medicinal chemistry applications, is molecules or compounds with similar 
structures will have similar biological activities[68,69]. Therefore, compounds with 
similar structures are predicted to have similar effects on the target or disease 
state of interest. This is one approach to finding new potential hit compounds: 
probing libraries of compounds to locate similar structures to the drug, ligand or 
inhibitor being investigated. Two other approaches that can predict inhibitors or 
ligands are analyzing the target or analyzing the dis ase state. Similarly, proteins 
that have similar sequences and/or function could have ligands that fit the target 
of interest. For example, ligands that work as inhibitors to the Rad51 protein may 
also inhibit the RecA protein due to the fact that they have similar functions and 
partial homology. Likewise, drugs available on the market that treat a specific 
disease state similar to the one of interest may also have medicinal effects to the 
disease of interest. Using this information to find target information is an indirect 
method due to off target effects and promiscuity of drugs. Disease states can have 
multiple enzymes, proteins and receptors involved, therefore attempting to find 
new drugs based on the disease state through the target can be tricky. See figure 
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5.1 to summarize the prediction methods. The method of interest in this project is 











Abstraction of Common Scaffolds from Seventy-three  
Hit Compounds from Biogen Library 
 
In an attempt to identify compounds that are active against the RecA 
protein, Dr. Tim Wigle was able to work in collaboration with Director Li-An 
Yeh and Professor Jonathon Sexton of the Biomanufacturing and Research 
Institute and Technology Enterprise located at North Carolina Central University 
to screen a small chemical library of 35,780 small molecules against the RecA 
protein. He utilized a phosphomolybdate blue ATPase say that measures 
ssDNA-dependent ATP hydrolysis as an indicator of activity of RecA by 
measuring the turnover of inorganic phosphates. Compounds that prevented the 
Figure 5.1. Prediction methods.  
The drug/ligand/inhibitor compounds can be used to irectly probe the target and disease 
state. The target (protein, enzyme, receptor) can be used to directly probe the 
drug/ligand/inhibitor and indirectly probe the disea  state. The disease state can be used 















production of inorganic phosphates from ATP would be considered active. From 
this compound library of 35,780 compounds, seventy-three hit compounds 
screened against the RecA protein were discovered. S ven common scaffolds 
from these seventy-three compounds were derived using Molecular Operating 
Environment (MOE), two of the scaffolds being unique. The seventy-three hits 
were condensed down to forty-eight unique structures, eliminating duplicates or 
isomers.  
Again, theoretically, compounds with similar structures should have similar 
activities. Therefore, exploring the literature for compounds that are already 
known and have structural similarity to the unique scaffolds could yield new 
potential inhibitors of RecA. Figure 2.1 demonstrates the general workflow of this 
project. 
 
Screening Literature for Similar Compounds  
Using SciFinder Scholar 
 
In order to obtain known or commercially available similar compounds, 
three scaffolds were used as query structures in ScFinder Scholar. As stated, there 
were two unique scaffolds were abstracted using MOE. Two of the scaffolds used 
to search SciFinder Scholar were very similar, differ ng only by an aromatic ring 
on one position of the main ring and an oxygen substit ent on another ring on 
only one scaffold. The third scaffold had a different composition. The search 
criteria included returning structures as organics and all others, single components 
and one or more reference available.  
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This process yielded three hundred and fifty-six comp unds (two hundred 
and ninety-seven for the first scaffold, thirty-three for the second scaffold and 
twenty-six for the third, different scaffold). Ninety-two of these compounds were 
randomly selected to represent all of the compounds to condense the amount of 
compounds needed for clustering. These representative compounds were 
converted into simplified molecular input line entry specification (SMILES) 
format, which describes chemical structures in short American Standard Code for 
Information Interchange (ASCII) strings.  
Two subsets of compounds now exist: the experimental set consisting of 
the forty-eight unique structures from the hit compounds (assigned an activity of 
one for modeling purposes) and the literature set consisting of the ninety-two 
compounds selected from the literature (assigned an activity of zero for modeling 
purposes). 
 
Tanimoto Similarity Coefficients Allow for  
Clustering in Activity Space 
 
There are many ways to describe compounds. These include physico-
chemical descriptors; which encompass logP (hydrophobicity), Van der Waals 
interactions, solubility, ionization constant, molecular weight, electronic 
properties (electronegativity and polarizability) and atom, bond, ring, functional 
group counts; and pharmacological descriptors, which comprise of toxicity, 
binding interactions, biological target, anti-pathogenic capabilities and activity 
(IC50, EC50, etc.). The focus of this project was atom, bond, ring, and functional 
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group counts, which allows for ligand fingerprinting using Tanimoto similarity 
coefficients[69,70].  
Ligand fingerprinting is a method of representing chemical data of a 
molecule in numerical form. Each compound in this project (forty-eight 
experimental compounds and ninety-two literature comp unds) was broken down 
into chemical fragments or bits, which are atoms, functional groups, covalent 
bonds, rings, etc. The calculated value of similarity between two ligand 
fingerprints is termed a Tanimoto similarity score, which is calculated with the 
following formula[70] (bits are set to one when the chemical fragment is pre ent in 
the molecules and are assigned zero when the chemical fragment is not present): 
 
where T is the Tanimoto score, Na is the number of bits set to one in the 
fingerprint of ligand a, Nb is the number of bits set to one in the fingerprint of 
ligand b and Nc is total number of bits set to one found in the fingerprints of both 
ligand a and b. A Tanimoto score is designated a value between zero and one with 
zero indicating no similarity and one indicating 100% similarity. A Tanimoto 
score ≥  0.7  is indicative of two molecules having high structural similarity, 
which is indicative of similar biological activity. 
As explained, each inhibitor compound is broken down into chemical 
fragments. When the fragment is present, the compound is assigned a value of 
one. If it absent, it is assigned a value of zero. All of these numbers are averaged, 
yielding a similarity score between zero and one. Compounds were characterized 
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according to similarity within their structures, forming various clusters in activity 
space (each cluster varying in numbers of experimental a d literature structures). 
The fragments are aligned on the top axis of a cluster map. Each compound 
extracted from the literature is analyzed for these fragments. Each compound 
(experimental and literature) is aligned on the y-axis and compared to the 
chemical fragments. When these clusters were mapped employing Tanimoto 
similarity coefficients in comparison to the experimental set, black spots indicated 
a strong correlation between structures; red spots indicated a weak correlation and 
varying levels of correlation existed in between (Figure 5.2). 
Upon analysis of the cluster map, many of the compounds extracted from 
the literature were similar to each other, meaning they have many of the same 
chemical fragments (Figure 5.3). Further examinatio uncovered four structures 
that were similar to the forty-eight hit compounds (Figure 5.3).  Compound 





Figure 5.2. Clustering the molecules in activity space utilizing Tanimoto similarity coefficients.  
The experimental and literature compounds are aligned along the Y-axis and the chemical fragments or 
bits are aligned the X-axis. Black squares represent active compounds (similar structures to tested 













Figure 5.3.  Sections of the cluster map.  
 
All of the compounds (experimental and literature) are aligned along the Y-axis of the 
cluster map. The chemical fragments (or bits) are aligned along the X-axis. Closer 
observations of the upper left section with many black spots reveals the similarity amongst 
the literature compounds. The middle right section with many black spots reveals four 
structures from the literature that have high similarity to the experimental hits, which are 
indicated with blue arrows and boxes. 
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AutoQSAR Analysis Predicts Activity Based  
on Structure Similarity 
 
Quantitative structure-activity relationship (QSAR) analysis predicts 
biological activity based on structure similarity, assuming there is a correlation 
between molecular structure and biological activity[68,69]. Therefore, a correlation 
is made between molecular properties or descriptors, including type of atoms, 
type of bonds, ring structures, volume of the molecul , electronic and steric 
factors and topology of the molecules. For this type of analysis to work, 
biological activity needs to be available. IC50 values from the hit compounds were 
used as a basis for this prediction method, again using the MOE program. 
Compounds from the literature that were intentionally kept inactive for 
mapping purposes are designated projected activities based on descriptor and 
activity space (i.e. chemical fragments). The predicte  activities can be ranked 
and prioritized; the most likely inhibitor candidates have a higher calculated 
value. The four compounds shown in the cluster map to be similar to the hit 
compounds had calculated activity values higher than 0.5 (0.5 would correlate to a 
percent inhibition of 50%). Twelve other compounds al o were shown to have 
predicted activities greater than 0.5 (table 5.1). Due to the fact that these 
















84 0 0.5043 
85 0 0.5449 
86 0 0.5500 
87 0 0.5500 
88 0 0.5500 
90 0 0.5649 
91 0 0.5735 
92 0 0.5735 
93 0 0.5821 
95 0 0.6097 
102 0 0.6524 
103 0 0.6524 
108 0 0.6537 
124 0 0.6856 
125 0 0.6868 















The goal of this project was to attempt to find comp unds that were 
already easily obtainable, preferably commercially available. The SciFinder 
search and AutoQSAR produced some new, interesting potential hits, but 
obviously did not entirely correspond with our demands. Therefore, I took the 
three scaffolds in our original search and ran the search again, but this time 
searching under the following conditions: returning structures as organics and all 
others, single components, one or more reference available and commercially 
Table 5.1 . AutoQSAR (PLS) results. 
 
Molecules extracted from the literature ‘intentionally’ kept inactive show 
projected activity based on chemical descriptor/activity space. The higher the 
calculated value, the more promising is the candidate. 
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available compounds only. This process yielded a tot l f thirteen compounds: 
one from scaffold one, three from scaffold two and ten from scaffold three. Two 
were purchased from scaffold two and five were purchased from scaffold three. 
For some compounds, the exact compound was not purchased due to cost 
effectiveness, but one very similar in its place was purchased.  
The PMB screening assay was utilized to determine the IC50 values of the 
purchased compounds against the RecA protein. Of the seven compounds tested, 






Thus far, this collaborative project has not generated any new potential 
hits against the RecA protein. One can assume the reason for this is the lack of 
negative hits within the search. The only data avail ble to us during at the time 
was the structures of the seventy-three hit compounds. The structures of the other 
three thousand five hundred and three compounds were unobtainable. Molecular 
modeling is only truly effective when accurate models can be created, which 
requires negative hits to distinguish between subtleties within structures that may 
alter the effectiveness of the ligand to the target.  
Currently, we have more data for lead compounds screened against RecA, 
as well as structures of negative hits (including the seven screened here and from 
other screens). Other libraries and compounds that have been screened include the 
LOPAC library (1281 compounds, 17 hits, 0.7% hit rate), the NCI library (2104 
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compounds, 3 hits, 0.14% hit rate), the Asinex library (hits only, 30 hits, 0.07% 
hit rate), the Harvard ICCB library (55 compounds, 6 hits, 16% hit rate) and 
natural products (13 compounds, 6 hits, 46% hit rate). Structural activity 
relationship studies were also done on two of the common scaffolds in the 
seventy-three hits from the library from the BRITE center (also the unique 
scaffolds extracted with MOE). This study composed of sixteen compounds 
synthesized by Dr. Anna Gromova in our laboratory, which produced seven hits at 
a 44% hit rate.  
With all of this new data compiled, we can create a new database of our 
own consisting of 3565 compounds, 123 hits and 3442 negatives. This would be 
an excellent foundation to begin this project at step one. New scaffolds can be 
abstracted and searched in SciFinder, then the hits can be selected for translation 
in to SMILES format, which can then be clustered in activity space in search of 
new potential hits. MOE can give initial hits, but perhaps another method of 
model generation, such as kNN (k-nearest neighbor algorithm), can be 
implemented to really narrow down hits before they are tested in the laboratory in 
order to maximize time and cost effectiveness. 
This project has immense probability to unearth new potential 
inhibitors of RecA.  The time and cost saved will also be invaluable.  
Hopefully in the not too distant future, the collaborative efforts between the 
Singleton laboratory and the Tropsha laboratory will be exhibit fruitfulness 
in our efforts to discover RecA inhibitors and to the fights against bacterial 










The introduction of antibiotics was by far one of the most crucial medical 
advancements made in the twentieth century. Upon their launch into society, the 
lives of many were spared, especially those who fought in World War II. 
However, when penicillin was finally given to patients, Fleming himself warned 
about the implications of underdosage that so easily leads to resistance. Over the 
past fifty years or so, many antibiotics have been misused or over-prescribed to 
patients thus leading to the rise in antibiotic resistant strains of infectious bacteria. 
Regretfully, at the close of the twentieth and opening of the twenty-first century, 
antibiotic resistance has risen to exorbitant propotions and those infectious 
diseases that claimed the lives of so many in the early twentieth century are once 
again an immense concern. Funding for antibacterial research is dwindling due to 
excessive expense of research, the short-comings of target based design and the 
short shelf life of antibiotics[projan].  As demonstrated with the rise of resistance, 
bacteria are highly adaptable and have a remarkable c pability of eliminating their 
susceptibility to antibiotics. Therefore, merely killing bacteria with new chemical 
agents is no longer the answer. New strategies need to be implemented.  
Theoretically speaking, if the mechanisms by which bacteria become 
resistant, inhibiting these mechanisms may just be the answer to this crisis. 
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Acquired resistance, occurring in only select isolates of a particular species, can 
be spread to other bacteria through mobile genetic elements or can be developed 
through de novo mutations. Since the RecA protein has been implicated in both of 
these processes (by aiding homologous recombination of resistant genes into the 
host genome and through SOS induction leading to mutagenesis)[4,5,7, 19-35], it is a 
novel target for combating antibiotic resistance. Hindering RecA’s involvement in 
DNA repair, horizontal gene transfer and stress-induce  SOS mutagenesis could 
potentially lead to a drastic reduction in the spreading of resistant genes and 
increased efficacy of current antibiotics that normally would have lost their 
therapeutic effects. Dr. Tim Wigle was able to test various classes of compounds 
for inhibitory effects against the RecA protein, which included metal cations, 
nucleotide analogs, and small drug-like molecules[Wigle]. One of the most 
promising candidates, designated A1, came from a Biogen Indec compound 
library. A1 was shown to inhibit the RecA-mediated SOS induction when 
administered to live bacteria in conjunction with ciprofloxacin and increased the 
toxicity of ciprofloxacin when added to cultures, thus rendering the bacteria 
unable to survive by inactivating RecA and therefor DNA repair pathways and 
SOS mutagenesis.  
Since this compound proved to be a promising candidate to inhibit RecA 
and therefore resistance mechanisms, I decided to study this compound in a 
prolonged assay that would observe not just the viability of cells with A1 
(meaning the first eight hours of culture), but for one-hundred hours, which would 
give more time to observe resistance onset. I chose chloramphenicol to start, since 
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experiments have been well characterized with resistance assays in our laboratory 
and it serves as a vital control experiment, since chloramphenicol resistance 
development does not necessarily utilize RecA. After conducting the one-flask 
resistance assay with chloramphenicol, upon administration of sub-lethal dosages 
of chloramphenicol, resistance to this antibiotic was observed in E. coli MG1655 
wild type and ∆recA cells. This result does clearly indicate that resistance to 
chloramphenicol is RecA independent. However, when A1 was added to the cells, 
resistance development was not observed in wild type or ∆recA cells. This result 
is rather perplexing, since A1 was clearly demonstrated to have inhibitory effects 
on the RecA protein, yet is able to prevent resistance development to an antibiotic 
that does not require the utilization of RecA within the cell. Thus, it may be 
conjectured that A1 is effective in preventing antibiotic resistance without a RecA 
effect.  
To further study A1 and possibly shed more light ono this somewhat 
contradictory data, the classic Griffith experiment was applied to E. coli cells. 
Assuming that E. coli is able to uptake exogenous DNA (as demonstrated by 
various research groups[39-45]), adding the supernatant of heat-killed 
chloramphenicol resistant cells would theoretically contain DNA encoding 
chloramphenicol resistance which would be absorbed in to the cell and 
incorporated into the host’s genome by a RecA dependent process. If this is able 
to occur, then resistance development to chloramphenicol would be observed at a 
faster rate than cells not in the presence of the heat-killed resistant cells. This 
proved to be true when the one-flask resistance assay was conducted. As a 
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negative control, ∆recA cells were used. This result supported the hypothesis that 
RecA would be needed to incorporate the resistant ge es, since ∆recA cells 
developed resistance to a sub-lethal dosage of chloramphenicol with the heat-
killed resistant cells at the same rate as the cells without the heat-killed resistant 
cells. However, this still does show that RecA is not eeded to develop resistance 
to chloramphenicol in general. The results of A1 added to the cultures further 
supports this conclusion. Again, A1 was able to attenuate the resistance 
development of MG1655 wild type and ∆recA cells to chloramphenicol, whether 
in the presence of heat-killed resistant cells or nt. A1 is potent in regards to 
hindering resistant development, however, it is disappointing to find that it may 
not be a RecA inhibitor as originally hypothesized.  
Lastly, the final project of this thesis involved the mining of compounds 
found in the literature for potential inhibitors ofRecA. Collaborating with Dr. 
Alexander Tropsha and Dr. M. Karthikayan in the UNC Eshelman School of 
Pharmacy, this was done by taking the hit compounds from the screen of the 
Biogen Indec library and extracting the common scaffolds which were input into 
SciFinder to obtain similar compounds, assuming that a positive correlation exists 
between chemical structure and biological activity[68,69]. From the structures 
obtained from the literature, similarity calculations were performed, as well as 
predictions based on the crude IC50 values from the hit compounds to predict 
possible activity of the compounds. Disappointingly, the compounds predicted to 
have the best activity were not commercially available. However, upon more 
searching, commercially available compounds were purchased and tested. 
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Unfortunately, the compounds were shown to be inactve against the RecA 
protein. Despite this fact, more libraries have been screened and can be utilized in 
the search. The project may still prove to be successful in finding inhibitors of 
RecA with the addition of the compounds from other libraries.  
The studies in this work may be taken further by applying other antibiotics 
to the resistance assays. Since ciprofloxacin was shown to have its toxicity greatly 
enhanced by the presence of A1 in viability assays, perhaps in resistance assays, 
the development of resistance will still be attenuated. Perhaps it will not if A1 
inhibits RecA independent mechanisms of resistance only. Other antibiotics 
would be interesting to study as well. Further elucidation of A1’s actions within 
the cells would be valuable in understanding its mode f action and therefore 
perhaps a new means of inhibiting antibiotic resistance, whether through RecA 
inhibition or not. A1 is a significant breakthrough in the battle against infectious 
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